LABEL>1
Interactions of the PROTEIN1 protein with itself and other members of the GE family, including PROTEIN2, GE, GE, and GE, were explored with a yeast two-hybrid system.
LABEL>1
Interactions of the PROTEIN1 protein with itself and other members of the GE family, including GE, PROTEIN2, GE, and GE, were explored with a yeast two-hybrid system.
LABEL>1
Interactions of the PROTEIN1 protein with itself and other members of the GE family, including GE, GE, PROTEIN2, and GE, were explored with a yeast two-hybrid system.
LABEL>1
Interactions of the PROTEIN1 protein with itself and other members of the GE family, including GE, GE, GE, and PROTEIN2, were explored with a yeast two-hybrid system.
LABEL>1
PROTEIN1 also interacted with PROTEIN2 and GE and with the dominant inhibitors GE and GE.
LABEL>1
PROTEIN1 also interacted with GE and PROTEIN2 and with the dominant inhibitors GE and GE.
LABEL>1
PROTEIN1 also interacted with GE and GE and with the dominant inhibitors PROTEIN2 and GE.
LABEL>1
PROTEIN1 also interacted with GE and GE and with the dominant inhibitors GE and PROTEIN2.
LABEL>1
The findings suggest a model whereby GE and GE differentially regulate GE function, and indicate that requirements for PROTEIN1/PROTEIN2 heterodimerization may be different from those for GE/GE homodimerization.
LABEL>1
The findings suggest a model whereby GE and GE differentially regulate GE function, and indicate that requirements for GE/GE heterodimerization may be different from those for PROTEIN1/PROTEIN2 homodimerization.
LABEL>1
Using immunoprecipitation techniques, we have determined the rates at which PROTEIN1 and GE (GE) are released from PROTEIN2 in a form committed to refold to active enzyme.
LABEL>1
Using immunoprecipitation techniques, we have determined the rates at which GE and PROTEIN1 (GE) are released from PROTEIN2 in a form committed to refold to active enzyme.
LABEL>1
Using immunoprecipitation techniques, we have determined the rates at which GE and GE (PROTEIN1) are released from PROTEIN2 in a form committed to refold to active enzyme.
LABEL>1
PROTEIN1 and GE were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable "folding arrested" complexes with PROTEIN2.
LABEL>1
GE and PROTEIN1 were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable "folding arrested" complexes with PROTEIN2.
LABEL>1
This suggests that PROTEIN1 must interact with PROTEIN2 throughout most of its folding reaction before it acquires a folding competent (groE independent) state.
LABEL>1
Interaction of PROTEIN1 and gamma c chains with PROTEIN2 and GE: implications for XSCID and XCID.
LABEL>1
Interaction of PROTEIN1 and gamma c chains with GE and PROTEIN2: implications for XSCID and XCID.
LABEL>1
PROTEIN1 and GE associated with PROTEIN2 and gamma c, respectively; GE induced GE-GE and increased GE-gamma c associations.
LABEL>1
GE and PROTEIN1 associated with PROTEIN2 and gamma c, respectively; GE induced GE-GE and increased GE-gamma c associations.
LABEL>1
GE and GE associated with GE and gamma c, respectively; GE induced PROTEIN1-PROTEIN2 and increased GE-gamma c associations.
LABEL>1
The PROTEIN1 and GE receptors (PROTEIN2 and GE, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
LABEL>1
The GE and PROTEIN1 receptors (GE and PROTEIN2, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
LABEL>1
In the case of GE, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. GE does not bind to the GE receptor, but PROTEIN1 binds to both the PROTEIN2 and GE, and mutagenesis studies have shown that the receptor-binding sites on GE overlap.
LABEL>1
In the case of GE, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. GE does not bind to the GE receptor, but PROTEIN1 binds to both the GE and PROTEIN2, and mutagenesis studies have shown that the receptor-binding sites on GE overlap.
LABEL>1
We present here the crystal structure of the 1:1 complex of PROTEIN1 bound to the extracellular domain of the PROTEIN2.
LABEL>1
Comparisons with the PROTEIN1-PROTEIN2 complex reveal how GE can bind to the two distinctly different receptor binding surfaces.
LABEL>1
These antibodies specifically immunoprecipitate PROTEIN1 in complex with PROTEIN2 in all tissues tested and can be used to immunoaffinity isolate progesterone receptor complexes from chicken oviduct cytosol.
LABEL>1
cDNA clones encoding a human PROTEIN1 (GE) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN2 specifically.
LABEL>1
cDNA clones encoding a human GE (PROTEIN1) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN2 specifically.
LABEL>1
The predicted amino acid sequence of GE is 60% identical and 73% similar to mouse GE (GE). PROTEIN1 expressed in an GE-dependent mouse pro-B cell line (Ba/F3) binds PROTEIN2 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to GE.
LABEL>1
PROTEIN1: a protein kinase stimulated by UV light and GE that binds and phosphorylates the PROTEIN2 activation domain.
LABEL>1
Significantly, PROTEIN1 partially activates PROTEIN2 and potentiates the activation caused by UV.
LABEL>1
PROTEIN1 binds to the PROTEIN2 transactivation domain and phosphorylates it on Ser-63 and Ser-73.
LABEL>1
PROTEIN1 is a ligand for the PROTEIN2CGE.
LABEL>1
We report here that recombinant PROTEIN1 induces autophosphorylation of PROTEIN2 in intact cells, consistent with GE being an authentic ligand for GE.
LABEL>1
We report here that recombinant GE induces autophosphorylation of GE in intact cells, consistent with PROTEIN1 being an authentic ligand for PROTEIN2.
LABEL>1
The cell surface form of PROTEIN1 is assembled during biosynthesis as a heteromeric complex with PROTEIN2 (GE), a type II transmembrane protein that is another member of the TNF ligand family.
LABEL>1
The cell surface form of PROTEIN1 is assembled during biosynthesis as a heteromeric complex with GE (PROTEIN2), a type II transmembrane protein that is another member of the TNF ligand family.
LABEL>1
Secreted GE is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface PROTEIN1-PROTEIN2 complex.
LABEL>1
Monoclonal antibodies to the beta chain of the GE receptor inhibited the biological activity of GE, and GE competed for binding with GE, indicating that PROTEIN1 uses components of the PROTEIN2L-GE.
LABEL>1
The POU domains of the PROTEIN1 and GE transcription factors mediate specific interaction with PROTEIN2.
LABEL>1
The POU domains of the GE and PROTEIN1 transcription factors mediate specific interaction with PROTEIN2.
LABEL>1
By using several different experimental systems we show that PROTEIN1 efficiently associates with PROTEIN2 and GE.
LABEL>1
By using several different experimental systems we show that PROTEIN1 efficiently associates with GE and PROTEIN2.
LABEL>1
We show that the POU homeodomain of PROTEIN1 and the evolutionarily conserved C-terminal core domain of PROTEIN2 are both required and sufficient for the interaction.
LABEL>1
The PROTEIN1 POU domain, which is highly homologous to the GE POU domain, likewise mediates interaction with PROTEIN2.
LABEL>1
The interaction can also be observed in vivo, as PROTEIN1 can be co-precipitated with PROTEIN2 from co-transfected Cos1 cells and GE co-immunoprecipitates with the endogenous GE from HeLa cells.
LABEL>1
The interaction can also be observed in vivo, as GE can be co-precipitated with GE from co-transfected Cos1 cells and PROTEIN1 co-immunoprecipitates with the endogenous PROTEIN2 from HeLa cells.
LABEL>1
Interaction of mammalian splicing factor PROTEIN1 with PROTEIN2 and relation of its 60-kD subunit to yeast GE.
LABEL>1
PROTEIN1 interacts with PROTEIN2 in the presence of GE to generate a structure similar to 17S GE, which suggests a function for GE and GE in the incorporation of GE into the spliceosome.
LABEL>1
The self-association site appears to be formed by interactions between helices 1 and 2 of PROTEIN1 repeat 17 of one dimer with helix 3 of PROTEIN2 repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.
LABEL>1
PROTEIN1, a human G1 and S phase protein phosphatase that associates with PROTEIN2.
LABEL>1
In yeast, PROTEIN1 interacts with cyclin-dependent kinases, including human PROTEIN2, GE, and GE, but not with GE.
LABEL>1
In yeast, PROTEIN1 interacts with cyclin-dependent kinases, including human GE, PROTEIN2, and GE, but not with GE.
LABEL>1
In yeast, PROTEIN1 interacts with cyclin-dependent kinases, including human GE, GE, and PROTEIN2, but not with GE.
LABEL>1
In HeLa cells, PROTEIN1 is expressed at the G1 to S transition, and the protein forms stable complexes with PROTEIN2.
LABEL>1
GE is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of GE by PROTEIN1-PROTEIN2, GE-GE, GE-GE, and GE-GE complexes.
LABEL>1
GE is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of GE by GE-GE, PROTEIN1-PROTEIN2, GE-GE, and GE-GE complexes.
LABEL>1
GE is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of GE by GE-GE, GE-GE, PROTEIN1-PROTEIN2, and GE-GE complexes.
LABEL>1
GE is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of GE by GE-GE, GE-GE, GE-GE, and PROTEIN1-PROTEIN2 complexes.
LABEL>1
Evidence for physical interaction between the zinc-finger transcription factors PROTEIN1 and PROTEIN2.
LABEL>1
We found that PROTEIN1 and PROTEIN2 can form a physical complex.
LABEL>1
In addition, we identified domains within PROTEIN1 and PROTEIN2 that mediate their interactions with each other.
LABEL>1
The physical interaction between PROTEIN1 and PROTEIN2 may thus form the basis for the functional interplay observed previously.
LABEL>1
The results showed that PROTEIN1 and GE can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene (PROTEIN2) expression in TF-1 cells.
LABEL>1
The results showed that GE and PROTEIN1 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene (PROTEIN2) expression in TF-1 cells.
LABEL>1
The PROTEIN1 associates with the PROTEIN2 catalytic subunit.
LABEL>1
In vitro-binding assays demonstrated that PROTEIN1 isoforms preferentially bind the hypophosphorylated form of PROTEIN2.
LABEL>1
Moreover, similar PROTEIN1 sequences are required for binding PROTEIN2 and GE.
LABEL>1
Moreover, similar PROTEIN1 sequences are required for binding GE and PROTEIN2.
LABEL>1
Characterization of the PROTEIN1 binding proteins PROTEIN2 and GE.
LABEL>1
Characterization of the PROTEIN1 binding proteins GE and PROTEIN2.
LABEL>1
We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, PROTEIN1 and GE, cloned originally by their interaction with PROTEIN2.
LABEL>1
We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, GE and PROTEIN1, cloned originally by their interaction with PROTEIN2.
LABEL>1
In addition we have been able to identify complexes of PROTEIN1 and PROTEIN2 in vivo that are dissociated in the presence of purified human papillomavirus GE protein.
LABEL>1
Two potentially oncogenic cyclins, PROTEIN1 and GE, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the PROTEIN2 protein
LABEL>1
Two potentially oncogenic cyclins, GE and PROTEIN1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the PROTEIN2 protein
LABEL>1
Moreover, PROTEIN1 was found to be phosphorylated on tyrosine residues in vivo and, like GE, was readily phosphorylated by PROTEIN2 in vitro.
LABEL>1
Moreover, GE was found to be phosphorylated on tyrosine residues in vivo and, like PROTEIN1, was readily phosphorylated by PROTEIN2 in vitro.
LABEL>1
In synchronized human osteosarcoma cells, PROTEIN1 is induced in early G1 and becomes associated with PROTEIN2, a Cdk-binding subunit.
LABEL>1
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN1 is associated with both PROTEIN2 and GE, and that GE immune complexes exhibit appreciable histone H1 kinase activity.
LABEL>1
Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN1 is associated with both GE and PROTEIN2, and that GE immune complexes exhibit appreciable histone H1 kinase activity.
LABEL>1
The SH2/SH3 domain-containing protein PROTEIN1 interacts with tyrosine-phosphorylated PROTEIN2 and GE: implications for insulin control of GE signalling.
LABEL>1
The SH2/SH3 domain-containing protein PROTEIN1 interacts with tyrosine-phosphorylated GE and PROTEIN2: implications for insulin control of GE signalling.
LABEL>1
The interactions between GE and these two proteins require ligand activation of the GE and are mediated by the binding of the SH2 domain of PROTEIN1 to phosphotyrosines on both PROTEIN2 and GE.
LABEL>1
The interactions between GE and these two proteins require ligand activation of the GE and are mediated by the binding of the SH2 domain of PROTEIN1 to phosphotyrosines on both GE and PROTEIN2.
LABEL>1
Although PROTEIN1 associates with PROTEIN2 and GE, it is not tyrosine-phosphorylated after GE stimulation, implying that GE is not a substrate for the insulin receptor.
LABEL>1
Although PROTEIN1 associates with GE and PROTEIN2, it is not tyrosine-phosphorylated after GE stimulation, implying that GE is not a substrate for the insulin receptor.
LABEL>1
Furthermore, we have identified a short sequence motif (YV/IN) present in PROTEIN1, GE and GE, which specifically binds the SH2 domain of PROTEIN2 with high affinity.
LABEL>1
Furthermore, we have identified a short sequence motif (YV/IN) present in GE, PROTEIN1 and GE, which specifically binds the SH2 domain of PROTEIN2 with high affinity.
LABEL>1
Furthermore, we have identified a short sequence motif (YV/IN) present in GE, GE and PROTEIN1, which specifically binds the SH2 domain of PROTEIN2 with high affinity.
LABEL>1
Interestingly, both PROTEIN1 and GE can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN2 molecule, suggesting a mechanism whereby GE could provide the core for a large signalling complex.
LABEL>1
Interestingly, both GE and PROTEIN1 can simultaneously bind distinct tyrosine phosphorylated regions on the same PROTEIN2 molecule, suggesting a mechanism whereby GE could provide the core for a large signalling complex.
LABEL>1
We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between PROTEIN1 and the two targets PROTEIN2 and GE.
LABEL>1
We propose a model whereby insulin stimulation leads to formation of multiple protein--protein interactions between PROTEIN1 and the two targets GE and PROTEIN2.
LABEL>1
Regulation of the GE-related transcription factor PROTEIN1 by binding to the PROTEIN2 protein.
LABEL>1
In this report, it is demonstrated that PROTEIN1 contains a sequence motif that is highly related to the GE binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN2 both in vitro and in vivo.
LABEL>1
Co-immunoprecipitation experiments demonstrated an association between PROTEIN1 and PROTEIN2 in resting normal human T cells.
LABEL>1
PROTEIN1-PROTEIN2 and GE-GE interactions define two distinct GE signal transduction pathways.
LABEL>1
GE-GE and PROTEIN1-PROTEIN2 interactions define two distinct GE signal transduction pathways.
LABEL>1
Here we show that PROTEIN1 directly interacts with PROTEIN2 and GE, signal transducers that activate GE and induce apoptosis, respectively.
LABEL>1
Here we show that PROTEIN1 directly interacts with GE and PROTEIN2, signal transducers that activate GE and induce apoptosis, respectively.
LABEL>1
Here we show that GE directly interacts with PROTEIN1 and GE, signal transducers that activate PROTEIN2 and induce apoptosis, respectively.
LABEL>1
Here we show that GE directly interacts with GE and PROTEIN1, signal transducers that activate PROTEIN2 and induce apoptosis, respectively.
LABEL>1
Characterization of PROTEIN1 binding to human PROTEIN2 on T cells and its biologic role in immune response.
LABEL>1
PROTEIN1, a T cell activation Ag, also known as GE,is directly associated with PROTEIN2 (GE) on the surface of T cells and T cell lines.
LABEL>1
PROTEIN1, a T cell activation Ag, also known as GE,is directly associated with GE (PROTEIN2) on the surface of T cells and T cell lines.
LABEL>1
GE, a T cell activation Ag, also known as PROTEIN1,is directly associated with PROTEIN2 (GE) on the surface of T cells and T cell lines.
LABEL>1
GE, a T cell activation Ag, also known as PROTEIN1,is directly associated with GE (PROTEIN2) on the surface of T cells and T cell lines.
LABEL>1
In the present study, we examined both the binding of PROTEIN1 and PROTEIN2 and the functional consequences of this interaction.
LABEL>1
We found that PROTEIN1 was associated with PROTEIN2 on T cell lines lacking either GE or GE enzymatic activity, indicating that the association between GE and GE did not require enzymatic activity.
LABEL>1
We found that GE was associated with GE on T cell lines lacking either GE or GE enzymatic activity, indicating that the association between PROTEIN1 and PROTEIN2 did not require enzymatic activity.
LABEL>1
These data suggest that GE on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN1 binds to cell surface PROTEIN2, and this complex is capable of reducing the local concentration of adenosine.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1, both beta 2- and GE interact with peptides encoding the syntrophin-binding region of PROTEIN2, GE/GEystrophiGE, and the GE.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1, both beta 2- and GE interact with peptides encoding the syntrophin-binding region of GE, PROTEIN2/GEystrophiGE, and the GE.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1, both beta 2- and GE interact with peptides encoding the syntrophin-binding region of GE, GE/PROTEIN2ystrophiGE, and the GE.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1, both beta 2- and GE interact with peptides encoding the syntrophin-binding region of GE, GE/GEystrophiGE, and the PROTEIN2.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like GE, both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN2, GE/GEystrophiGE, and the GE.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like GE, both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of GE, PROTEIN2/GEystrophiGE, and the GE.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like GE, both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of GE, GE/PROTEIN2ystrophiGE, and the GE.
LABEL>1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like GE, both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of GE, GE/GEystrophiGE, and the PROTEIN2.
LABEL>1
PROTEIN1: a kinase associated with the PROTEIN2.
LABEL>1
The pleiotropic biological activities of PROTEIN1 (GE) are mediated by its type I receptor (PROTEIN2).
LABEL>1
The pleiotropic biological activities of GE (PROTEIN1) are mediated by its type I receptor (PROTEIN2).
LABEL>1
When human embryonic kidney cells (cell line 293) over-expressing GE or HeLa cells were exposed to GE, PROTEIN1 rapidly associated with the PROTEIN2 complex and was phosphorylated.
LABEL>1
The death domain of PROTEIN1 (GE) triggers distinct signaling pathways leading to apoptosis and GE activation through its interaction with the death domain protein PROTEIN2.
LABEL>1
The death domain of GE (PROTEIN1) triggers distinct signaling pathways leading to apoptosis and GE activation through its interaction with the death domain protein PROTEIN2.
LABEL>1
Here, we show that PROTEIN1 interacts strongly with PROTEIN2, another death domain protein that was shown previously to associate with GE antigen.
LABEL>1
Here, we show that GE interacts strongly with PROTEIN1, another death domain protein that was shown previously to associate with PROTEIN2 antigen.
LABEL>1
The carboxy-terminal region of PROTEIN1 has previously been shown to interact directly with PROTEIN2, a cytoplasmic component of the GE-glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.
LABEL>1
Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, PROTEIN1, with another SH2-containing protein, PROTEIN2.
LABEL>1
PROTEIN1 associates with the PROTEIN2latelet-derived growth factoGEDGGE after ligand stimulation, and binding of GE to this receptor promotes tyrosine phosphorylation of GE.
LABEL>1
Using GE as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that PROTEIN1 interacts with another signaling protein, PROTEIN2.
LABEL>1
We demonstrate that PROTEIN1 binds to PROTEIN2 in vitro under conditions where the latter is tyrosine-phosphorylated.
LABEL>1
We found that the human PROTEIN1 (GE) physically interacted with PROTEIN2 via its DNA binding domain.
LABEL>1
We found that the human GE (PROTEIN1) physically interacted with PROTEIN2 via its DNA binding domain.
LABEL>1
As a result of this physical interaction, binding of PROTEIN1 to its hormone response elements either as homodimer or as a heterodimer with the PROTEIN2 was inhibited by GE in a concentration-dependent manner.
LABEL>1
In transfected cells, wild-type PROTEIN1 repressed the hormone-dependent transcriptional activation of PROTEIN2.
LABEL>1
A protein, PROTEIN1 (GE), was identified in a human cell line that bound to a region of the PROTEIN2 (GE) containing the lysosomal targeting code.
LABEL>1
A protein, PROTEIN1 (GE), was identified in a human cell line that bound to a region of the GE (PROTEIN2) containing the lysosomal targeting code.
LABEL>1
A protein, GE (PROTEIN1), was identified in a human cell line that bound to a region of the PROTEIN2 (GE) containing the lysosomal targeting code.
LABEL>1
A protein, GE (PROTEIN1), was identified in a human cell line that bound to a region of the GE (PROTEIN2) containing the lysosomal targeting code.
LABEL>1
The splicing factor U2AF (U2 snRNP auxiliary factor) is a heterodimer with subunits of 65 and 35 kD (PROTEIN1 and PROTEIN2).
LABEL>1
Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex GE, the nucleotide excision repair protein PROTEIN1, and GESGE.
LABEL>1
Our analyses demonstrate that the PROTEIN1, PROTEIN2, GE, and GE proteins interact with each other.
LABEL>1
PROTEIN1 protein interacts with multiple subunits of GE and with PROTEIN2 protein.
LABEL>1
Residues in human PROTEIN1 (GE) crucial for binding to both the human PROTEIN2 (R) and GE were identified by analysis of alanine scanning mutants of GE in assays for both receptor binding and bioactivity.
LABEL>1
Residues in human PROTEIN1 (GE) crucial for binding to both the human GE (R) and PROTEIN2 were identified by analysis of alanine scanning mutants of GE in assays for both receptor binding and bioactivity.
LABEL>1
Residues in human GE (PROTEIN1) crucial for binding to both the human PROTEIN2 (R) and GE were identified by analysis of alanine scanning mutants of GE in assays for both receptor binding and bioactivity.
LABEL>1
Residues in human GE (PROTEIN1) crucial for binding to both the human GE (R) and PROTEIN2 were identified by analysis of alanine scanning mutants of GE in assays for both receptor binding and bioactivity.
LABEL>1
The region of PROTEIN1 most important for binding to the PROTEIN2 is composed of residues from the amino terminus of the D-helix, carboxyl terminus of the B-helix, and C-D loop.
LABEL>1
The two residues of PROTEIN1 that contribute the majority of free energy for PROTEIN2 binding, Phe-156 and Lys-159 are surrounded by other residues which have only a moderate impact.
LABEL>1
A second region of PROTEIN1 that includes residues from the carboxyl terminus of the D-helix and A-B loop also had a weak influence on PROTEIN2 binding.
LABEL>1
Residues in PROTEIN1 from both the A- and C-helices are involved in binding the PROTEIN2 co-receptor.
LABEL>1
Abolition of the PROTEIN1 binding site in PROTEIN2 created antagonists of GE action.
LABEL>1
The PROTEIN1 glucose transporter interacts with PROTEIN2 and GE.
LABEL>1
The PROTEIN1 glucose transporter interacts with GE and PROTEIN2.
LABEL>1
Following immunoprecipitation with an anticalnexin antiserum, a cross-linker-independent association was observed between PROTEIN1 and PROTEIN2.
LABEL>1
In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of PROTEIN1 and a protein of approximately 60 kDa designated PROTEIN2 (GE of 60 kDa).
LABEL>1
In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of PROTEIN1 and a protein of approximately 60 kDa designated GE (PROTEIN2 of 60 kDa).
LABEL>1
Both the PROTEIN1-PROTEIN2 and the GE-GE interactions were dependent on the presence of a correctly modified oligosaccharide group on GE, a characteristic of many GE interactions.
LABEL>1
Both the GE-GE and the PROTEIN1-PROTEIN2 interactions were dependent on the presence of a correctly modified oligosaccharide group on GE, a characteristic of many GE interactions.
LABEL>1
PROTEIN1, the soluble homologue of GE, was also shown to interact with PROTEIN2 only when the protein bore a correctly modified oligosaccharide group.
LABEL>1
Thus, our data show that both PROTEIN1 and GE interact with PROTEIN2 in a glycosylation-dependent manner.
LABEL>1
Thus, our data show that both GE and PROTEIN1 interact with PROTEIN2 in a glycosylation-dependent manner.
LABEL>1
The PROTEIN1rythropoietiGE (PROTEIN2) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.
LABEL>1
We have used site-specific mutagenesis within the extracellular domain of the PROTEIN1 to search for amino acid residues involved in PROTEIN2 (GE) binding.
LABEL>1
We have used site-specific mutagenesis within the extracellular domain of the PROTEIN1 to search for amino acid residues involved in GE (PROTEIN2) binding.
LABEL>1
Mutant proteins were expressed in bacteria as soluble PROTEIN1 binding proteins (PROTEIN2) and characterized for GE binding activity in a number of different assays.
LABEL>1
Substitution of phenylalanine at position 93 (Phe93) with alanine (F93A mutation) resulted in a drastic reduction in PROTEIN1 binding in the PROTEIN2.
LABEL>1
Furthermore, the F93A mutation in full-length PROTEIN1 expressed in COS cells abolished detectable PROTEIN2 binding.
LABEL>1
These data indicate that Phe93 is a critical PROTEIN1 binding determinant of the PROTEIN2.
LABEL>1
We have cloned a cDNA encoding an PROTEIN1 binding protein (PROTEIN2) from the Caki-1 human renal carcinoma cell line.
LABEL>1
COS-7 cells transfected with the PROTEIN1 cDNA bind PROTEIN2 with high affinity but do not bind GE.
LABEL>1
The phagocyte GE is a complex of membrane GE (comprised of subunits PROTEIN1 and PROTEIN2) and three cytosol proteins (GE, GE, and GE) that translocate to membrane and bind to GE.
LABEL>1
The phagocyte GE is a complex of membrane GE (comprised of subunits GE and GE) and three cytosol proteins (PROTEIN1, PROTEIN2, and GE) that translocate to membrane and bind to GE.
LABEL>1
The phagocyte GE is a complex of membrane GE (comprised of subunits GE and GE) and three cytosol proteins (PROTEIN1, GE, and GE) that translocate to membrane and bind to PROTEIN2.
LABEL>1
The phagocyte GE is a complex of membrane GE (comprised of subunits GE and GE) and three cytosol proteins (GE, PROTEIN1, and GE) that translocate to membrane and bind to PROTEIN2.
LABEL>1
The phagocyte GE is a complex of membrane GE (comprised of subunits GE and GE) and three cytosol proteins (GE, GE, and PROTEIN1) that translocate to membrane and bind to PROTEIN2.
LABEL>1
This is the first report to demonstrate that two of cytosolic components of GE, PROTEIN1 binding to PROTEIN2 each other.
LABEL>1
Crystal structure of the PROTEIN1 cyclin-dependent-kinase inhibitor bound to the PROTEIN2-GE complex.
LABEL>1
Crystal structure of the PROTEIN1 cyclin-dependent-kinase inhibitor bound to the GE-PROTEIN2 complex.
LABEL>1
Crystal structure of the GE cyclin-dependent-kinase inhibitor bound to the PROTEIN1-PROTEIN2 complex.
LABEL>1
The crystal structure of the human PROTEIN1 inhibitory domain bound to the phosphorylated PROTEIN2-GE (GE) complex has been determined at 2.3 angstrom.
LABEL>1
The crystal structure of the human PROTEIN1 inhibitory domain bound to the phosphorylated GE-GE (PROTEIN2) complex has been determined at 2.3 angstrom.
LABEL>1
The crystal structure of the human GE inhibitory domain bound to the phosphorylated PROTEIN1-GE (PROTEIN2) complex has been determined at 2.3 angstrom.
LABEL>1
PROTEIN1 binds the complex as an extended structure interacting with both PROTEIN2 and GE.
LABEL>1
PROTEIN1 binds the complex as an extended structure interacting with both GE and PROTEIN2.
LABEL>1
PROTEIN1ascular endothelial growth factoGE: a ligand and specific activator of the tyrosine kinase receptor PROTEIN2.
LABEL>1
PROTEIN1 and GE have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN2 (GE).
LABEL>1
PROTEIN1 and GE have been shown to play key roles in vascular development; these two receptors bind and are activated by GE (PROTEIN2).
LABEL>1
GE and PROTEIN1 have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN2 (GE).
LABEL>1
GE and PROTEIN1 have been shown to play key roles in vascular development; these two receptors bind and are activated by GE (PROTEIN2).
LABEL>1
This protein, designated PROTEIN1EGGE (GE), specifically binds to the extracellular domain of PROTEIN2, stimulates the tyrosine phosphorylation of GE expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
LABEL>1
This protein, designated GEEGGE (PROTEIN1), specifically binds to the extracellular domain of PROTEIN2, stimulates the tyrosine phosphorylation of GE expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.
LABEL>1
GE protein fused to the Drosophila protein GE (GE-GE) failed to interact with the GE fragment fused to GE, indicating that the observed PROTEIN1-PROTEIN2 interaction was specific.
LABEL>1
The high affinity GE (GE) signaling complex consists of PROTEIN1 and two membrane-associated receptor components: a low affinity but specific PROTEIN2L-GE and the affinity converter/signal transducing protein GE.
LABEL>1
Monomeric (GE) and dimeric (GE) forms of Escherichia coli-derived human GE and the extracellular ("soluble") portions of the PROTEIN1L-GE (PROTEIN2) and GE have been purified in order to investigate the effect of GE dimerization on binding to the receptor complex.
LABEL>1
Although PROTEIN1 has a higher binding affinity for immobilized PROTEIN2, as determined by biosensor analysis employing surface plasmon resonance detection, GE is more potent than GE in a STAT3 phosphorylation assay.
LABEL>1
The increased binding affinity of PROTEIN1 appears to be due to its ability to cross-link two PROTEIN2 molecules on the biosensor surface.
LABEL>1
Studies of the GE ternary complex formation demonstrated that the reduced biological potency of GE resulted from a decreased ability of the PROTEIN1 (PROTEIN2)2 complex to couple with the soluble portion of GE.
LABEL>1
These data imply that GE-induced dimerization of GE is not the driving force in promoting formation of the hexameric (PROTEIN1 PROTEIN2 GE)2 complex.
LABEL>1
A model is presented whereby the trimeric complex of PROTEIN1, PROTEIN2, and GE forms before the functional hexamer.
LABEL>1
Due to its increased affinity for the PROTEIN1 but its decreased ability to couple with GE, we suggest that a stable PROTEIN2 dimer may be an efficient GE antagonist.
LABEL>1
Due to its increased affinity for the GE but its decreased ability to couple with PROTEIN1, we suggest that a stable PROTEIN2 dimer may be an efficient GE antagonist.
LABEL>1
Physical interaction of mammalian PROTEIN1 with PROTEIN2
LABEL>1
We have detected a specific association of PROTEIN1 with the molecular chaperon PROTEIN2 and a 44-kDa protein that we identify as mammalian GE.
LABEL>1
We have detected a specific association of PROTEIN1 with the molecular chaperon GE and a 44-kDa protein that we identify as mammalian PROTEIN2.
LABEL>1
A physical interaction between PROTEIN1 and PROTEIN2 suggests that GE may regulate the mammalian cell cycle through a direct effect on GE.
LABEL>1
A physical interaction between GE and GE suggests that PROTEIN1 may regulate the mammalian cell cycle through a direct effect on PROTEIN2.
LABEL>1
Association of PROTEIN1 with both PROTEIN2 and GE may also imply a mechanistic link between the functions of GE and GE.
LABEL>1
Association of PROTEIN1 with both GE and PROTEIN2 may also imply a mechanistic link between the functions of GE and GE.
LABEL>1
Interactions of PROTEIN1, a mediator of GE assembly, with heat shock proteins PROTEIN2 and GE.
LABEL>1
Interactions of PROTEIN1, a mediator of GE assembly, with heat shock proteins GE and PROTEIN2.
LABEL>1
Since PROTEIN1 is typically found in a complex with PROTEIN2 and GE, we have further characterized its interactions with these proteins.
LABEL>1
Since PROTEIN1 is typically found in a complex with GE and PROTEIN2, we have further characterized its interactions with these proteins.
LABEL>1
PROTEIN1 can bind either PROTEIN2 or GE independently and in an ATP-independent manner.
LABEL>1
PROTEIN1 can bind either GE or PROTEIN2 independently and in an ATP-independent manner.
LABEL>1
Since GE and GE do not readily associate on their own, it appears that GE is the central organizing component of an PROTEIN1-PROTEIN2-GE complex.
LABEL>1
Mutational analysis of PROTEIN1 indicates that the N terminus is required for PROTEIN2 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding GE and GE.
LABEL>1
Mutational analysis of PROTEIN1 indicates that the N terminus is required for GE binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding PROTEIN2 and GE.
LABEL>1
Mutational analysis of PROTEIN1 indicates that the N terminus is required for GE binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding GE and PROTEIN2.
LABEL>1
The PROTEIN1-PROTEIN2-GE multichaperone complex is highly dynamic and does not appear to be affected by the GE-binding drug geldanamycin.
LABEL>1
The interactions of PROTEIN1 and PROTEIN2 in intermediate GE complexes are shown to be distinct from their separate interactions in early GE complexes (GE) or in mature GE complexes (hsp90).
LABEL>1
We have selected such mutations in the transcription factor PROTEIN1 that affect its ability to heterodimerize with PROTEIN2.
LABEL>1
In vitro and in nonproliferating cells, PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either PROTEIN2, GE, or GE.
LABEL>1
In vitro and in nonproliferating cells, PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either GE, PROTEIN2, or GE.
LABEL>1
In vitro and in nonproliferating cells, PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either GE, GE, or PROTEIN2.
LABEL>1
In addition, PROTEIN1 associates with three different CDKs: PROTEIN2, GE, and GE.
LABEL>1
In addition, PROTEIN1 associates with three different CDKs: GE, PROTEIN2, and GE.
LABEL>1
In addition, PROTEIN1 associates with three different CDKs: GE, GE, and PROTEIN2.
LABEL>1
The amount of PROTEIN1 and GE associated with PROTEIN2 does not change in a cell cycle-dependent fashion; in contrast, the amount of GE associated with GE is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
LABEL>1
The amount of GE and PROTEIN1 associated with PROTEIN2 does not change in a cell cycle-dependent fashion; in contrast, the amount of GE associated with GE is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
LABEL>1
The amount of GE and GE associated with GE does not change in a cell cycle-dependent fashion; in contrast, the amount of PROTEIN1 associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.
LABEL>1
In contrast, PROTEIN1 complexes containing PROTEIN2 are incapable of phosphorylating GE.
LABEL>1
PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2PROTEIN3 receptoGE and its association with GE and the GE.
LABEL>1
GE stimulates tyrosine phosphorylation of PROTEIN1PROTEIN2 receptoGE and its association with PROTEIN3 and the GE.
LABEL>1
GE stimulates tyrosine phosphorylation of PROTEIN1PROTEIN2 receptoGE and its association with GE and the PROTEIN3.
LABEL>1
In the present study, we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2nsuliGE (GE), the major cytoplasmic substrate of the GEnsuliGE.
LABEL>1
In the present study, we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of GEnsuliGE (PROTEIN2), the major cytoplasmic substrate of the GEnsuliGE.
LABEL>1
The PROTEIN1-induced phosphorylation of PROTEIN2 was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.
LABEL>1
Following GE stimulation, we observed a time- and dose-dependent association of PROTEIN1 with the GE regulatory subunit of PROTEIN2 (GE).
LABEL>1
Following GE stimulation, we observed a time- and dose-dependent association of PROTEIN1 with the GE regulatory subunit of GE (PROTEIN2).
LABEL>1
We have previously reported that tyrosine phosphorylation of PROTEIN1 and its association with the PROTEIN2-GE complex may contribute to the activation of the GE pathway by GE.
LABEL>1
We have previously reported that tyrosine phosphorylation of PROTEIN1 and its association with the GE-PROTEIN2 complex may contribute to the activation of the GE pathway by GE.
LABEL>1
We have previously reported that tyrosine phosphorylation of GE and its association with the PROTEIN1-PROTEIN2 complex may contribute to the activation of the GE pathway by GE.
LABEL>1
We report here that PROTEIN1 also interacts with tyrosine-phosphorylated PROTEIN2 in response to GE.
LABEL>1
PROTEIN1 (GE, GE, GE), a PROTEIN2 (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
PROTEIN1 (GE, GE, GE), a GE (PROTEIN2) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
GE (PROTEIN1, GE, GE), a PROTEIN2 (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
GE (PROTEIN1, GE, GE), a GE (PROTEIN2) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
GE (GE, PROTEIN1, GE), a PROTEIN2 (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
GE (GE, PROTEIN1, GE), a GE (PROTEIN2) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
GE (GE, GE, PROTEIN1), a PROTEIN2 (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
GE (GE, GE, PROTEIN1), a GE (PROTEIN2) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>1
In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN1 and the GE, PROTEIN2 (GE).
LABEL>1
In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN1 and the GE, GE (PROTEIN2).
LABEL>1
PROTEIN1 phosphorylates PROTEIN2 on serine 41.
LABEL>1
Surprisingly, the N-terminal third of PROTEIN1 alone bound PROTEIN2 more strongly than did intact GE, suggesting that the protein's C-terminus may play a role in modulating the interaction with GE.
LABEL>1
Surprisingly, the N-terminal third of GE alone bound PROTEIN1 more strongly than did intact PROTEIN2, suggesting that the protein's C-terminus may play a role in modulating the interaction with GE.
LABEL>1
These results, along with other recent findings, suggest a novel role for the interaction between PROTEIN1 and PROTEIN2.
LABEL>1
Structure of the PROTEIN1 tumor suppressor bound to the ankyrin and SH3 domains of PROTEIN2.
LABEL>1
The core domain contains the sequence-specific DNA binding activity and the in vitro PROTEIN1 protein binding activity of PROTEIN2.
LABEL>1
The crystal structure of the PROTEIN1 core domain bound to the PROTEIN2 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of GE in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of GE.
LABEL>1
The structure of the complex shows that the PROTEIN1 binding site on the PROTEIN2 core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding.
LABEL>1
The six most frequently observed PROTEIN1 mutations disrupt PROTEIN2 binding in vitro.
LABEL>1
The structure provides evidence that the PROTEIN1-PROTEIN2 complex forms in vivo and may have a critical role in the GE pathway of tumor suppression.
LABEL>1
Structure of the PROTEIN1 oncoprotein bound to the PROTEIN2 tumor suppressor transactivation domain.
LABEL>1
The PROTEIN1 oncoprotein is a cellular inhibitor of the PROTEIN2 tumor suppressor in that it can bind the transactivation domain of GE and downregulate its ability to activate transcription.
LABEL>1
The PROTEIN1 oncoprotein is a cellular inhibitor of the GE tumor suppressor in that it can bind the transactivation domain of PROTEIN2 and downregulate its ability to activate transcription.
LABEL>1
The crystal structure of the 109-residue amino-terminal domain of PROTEIN1 bound to a 15-residue transactivation domain peptide of PROTEIN2 revealed that GE has a deep hydrophobic cleft on which the GE peptide binds as an amphipathic alpha helix.
LABEL>1
The crystal structure of the 109-residue amino-terminal domain of GE bound to a 15-residue transactivation domain peptide of GE revealed that PROTEIN1 has a deep hydrophobic cleft on which the PROTEIN2 peptide binds as an amphipathic alpha helix.
LABEL>1
The interface relies on the steric complementarity between the GE cleft and the hydrophobic face of the GE alpha helix and, in particular, on a triad of PROTEIN1 amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN2 cleft.
LABEL>1
These same GE residues are also involved in transactivation, supporting the hypothesis that PROTEIN1 inactivates PROTEIN2 by concealing its transactivation domain.
LABEL>1
The cytokine-activated tyrosine kinase PROTEIN1 activates PROTEIN2 in a GE-dependent manner.
LABEL>1
PROTEIN1, a member of the Janus kinase superfamily was found to interact functionally with PROTEIN2, a central component of the GE/GE signal transduction pathway.
LABEL>1
PROTEIN1 and several other cytokines that are known to activate PROTEIN2AKGE were also found to stimulate GEaf-GE activity toward GE in mammalian cells.
LABEL>1
GE and several other cytokines that are known to activate GEAKGE were also found to stimulate PROTEIN1af-GE activity toward PROTEIN2 in mammalian cells.
LABEL>1
In the baculovirus coexpression system, PROTEIN1 was activated by PROTEIN2 in the presence of GE.
LABEL>1
Under these conditions, a ternary complex of PROTEIN1, PROTEIN2, and GE was observed.
LABEL>1
In addition, PROTEIN1 phosphorylated PROTEIN2 at sites different from those phosphorylated by GE.
LABEL>1
In addition, GE phosphorylated PROTEIN1 at sites different from those phosphorylated by PROTEIN2.
LABEL>1
In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of PROTEIN1 coimmunoprecipitated with PROTEIN2 in lysates of cells in which GE was activated as judged by its state of tyrosine phosphorylation.
LABEL>1
Taken together, these data suggest that PROTEIN1 and PROTEIN2 cooperate to activate GE.
LABEL>1
PROTEIN1-induced interaction of primary HIV-1 PROTEIN2 glycoproteins with the chemokine receptor GE.
LABEL>1
Here we show that a complex of PROTEIN1, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN2 interacts specifically with GE and inhibits the binding of the natural GE ligands, GE and GE (refs 7, 8).
LABEL>1
Here we show that a complex of PROTEIN1, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with PROTEIN2 and inhibits the binding of the natural GE ligands, GE and GE (refs 7, 8).
LABEL>1
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with PROTEIN2 and inhibits the binding of the natural GE ligands, GE and GE (refs 7, 8).
LABEL>1
The apparent affinity of the interaction between PROTEIN1 and PROTEIN2 was dramatically lower in the absence of soluble GE.
LABEL>1
Additionally, in the absence of GE, an interaction between a two-domain PROTEIN1 fragment and PROTEIN2 was observed.
LABEL>1
A PROTEIN1 fragment retaining the PROTEIN2-binding site and overlapping epitopes was able to interact with GE only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.
LABEL>1
A PROTEIN1 fragment retaining the GE-binding site and overlapping epitopes was able to interact with PROTEIN2 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.
LABEL>1
Neutralizing antibodies directed against either GE-induced or V3 epitopes on GE blocked the interaction of PROTEIN1-PROTEIN2 complexes with GE.
LABEL>1
Neutralizing antibodies directed against either GE-induced or V3 epitopes on GE blocked the interaction of PROTEIN1-GE complexes with PROTEIN2.
LABEL>1
Neutralizing antibodies directed against either GE-induced or V3 epitopes on GE blocked the interaction of GE-PROTEIN1 complexes with PROTEIN2.
LABEL>1
PROTEIN1 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the PROTEIN2nterleukin-1GE intracellular domain.
LABEL>1
In all cells tested, PROTEIN1 activated PROTEIN2 and GE and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
LABEL>1
In all cells tested, PROTEIN1 activated GE and PROTEIN2 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
LABEL>1
PROTEIN1 also activated PROTEIN2 in Ba/F3 cells that stably expressed the murine GEL-1GE.
LABEL>1
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1L-1GE were found to be redundantly required for receptor function and for activation of PROTEIN2 but not for GE or Stat5.
LABEL>1
These data demonstrate that PROTEIN1 but not GE or GE is directly recruited to the ligand-activated PROTEIN2L-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>1
Only weak PROTEIN1 binding activity was found in cells transfected with only PROTEIN2; however, the combination of both GE and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the GEL-1GE.
LABEL>1
Whereas PROTEIN1 serves as an alternative accessory protein to the common GE (GE) for PROTEIN2 signaling, it could not replace the function of GE in allowing enhanced GE binding activity.
LABEL>1
Interaction of PROTEIN1 with PROTEIN2: binding and inhibition of amyloid formation.
LABEL>1
PROTEIN1 (GE), a second major CSF protein, formed SDS-stable complexes with PROTEIN2 and significantly decreased the rate of GE fibril formation.
LABEL>1
GE (PROTEIN1), a second major CSF protein, formed SDS-stable complexes with PROTEIN2 and significantly decreased the rate of GE fibril formation.
LABEL>1
Endogenous PROTEIN1-PROTEIN2 complexes were detected in human CSF by immunoprecipitation.
LABEL>1
Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the PROTEIN1 monomer that interact with PROTEIN2.
LABEL>1
Associations of PROTEIN1 with PROTEIN2, GE, GE, and GE proteins in a yeast two-hybrid system.
LABEL>1
Associations of PROTEIN1 with GE, PROTEIN2, GE, and GE proteins in a yeast two-hybrid system.
LABEL>1
Associations of PROTEIN1 with GE, GE, PROTEIN2, and GE proteins in a yeast two-hybrid system.
LABEL>1
Associations of PROTEIN1 with GE, GE, GE, and PROTEIN2 proteins in a yeast two-hybrid system.
LABEL>1
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated PROTEIN1, that interacts with PROTEIN2, GE, GE, and a ubiquitin-like protein GE.
LABEL>1
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated PROTEIN1, that interacts with GE, PROTEIN2, GE, and a ubiquitin-like protein GE.
LABEL>1
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated PROTEIN1, that interacts with GE, GE, PROTEIN2, and a ubiquitin-like protein GE.
LABEL>1
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated PROTEIN1, that interacts with GE, GE, GE, and a ubiquitin-like protein PROTEIN2.
LABEL>1
The interaction of PROTEIN1 with PROTEIN2 is mediated by GE's self-association region.
LABEL>1
Discrete protein interactions with the PROTEIN1/PROTEIN2 complex in GE- and GE-mediated myeloid cell proliferation.
LABEL>1
In the present study we evaluated tyrosine phosphorylation of GE and the interaction of the PROTEIN1/PROTEIN2 complex with signaling proteins upon activation of non-tyrosine (GE) and tyrosine kinase (GE) receptors leading to myeloid cell proliferation.
LABEL>1
By using the growth factor dependent M-07e cell line, we found that both GE and GE ligands, namely: PROTEIN1 and GE, induce PROTEIN2 tyrosine phosphorylation.
LABEL>1
By using the growth factor dependent M-07e cell line, we found that both GE and GE ligands, namely: GE and PROTEIN1, induce PROTEIN2 tyrosine phosphorylation.
LABEL>1
In these cells the adaptor protein PROTEIN1 constitutively binds a substantial fraction of PROTEIN2 through the N-terminal SH3 domain.
LABEL>1
In vitro experiments showed that the stable PROTEIN1/PROTEIN2 complex interacts, through the GE SH2 domain, with the GE-activated GE.
LABEL>1
In vitro experiments showed that the stable GE/GE complex interacts, through the PROTEIN1 SH2 domain, with the GE-activated PROTEIN2.
LABEL>1
In vitro experiments showed that the stable GE/GE complex interacts, through the GE SH2 domain, with the PROTEIN1-activated PROTEIN2.
LABEL>1
By contrast stimulation with GE leads to the formation of a PROTEIN1 complex containing PROTEIN2.
LABEL>1
In vitro and in vivo experiments support the hypothesis that GE mediates the association of PROTEIN1 with PROTEIN2.
LABEL>1
Moreover we found that, upon GE stimulation, the PROTEIN1/PROTEIN2 complex recruits GE, probably via GE.
LABEL>1
Moreover we found that, upon GE stimulation, the GE/GE complex recruits PROTEIN1, probably via PROTEIN2.
LABEL>1
By contrast the PROTEIN1 exchanger factor (PROTEIN2) was not detected in anti-GE immunoprecipitates suggesting that GE/GE and GE/GE are present in different complexes.
LABEL>1
Taken together our results demonstrate that GE plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with PROTEIN1/PROTEIN2 complex when non-tyrosine or tyrosine kinase receptors are activated.
LABEL>1
PROTEIN1 interacts with PROTEIN2 and GE with GE receptors.
LABEL>1
GE interacts with GE and PROTEIN1 with PROTEIN2 receptors.
LABEL>1
Activation of PROTEIN1nterferon-gammGE mediated by PROTEIN2nterleukin-1betGE.
LABEL>1
The PROTEIN1nterleukin-1betGEL-1betGE (PROTEIN2) processes the inactive GE precursor to the proinflammatory cytokine.
LABEL>1
The GEnterleukin-1betGEL-1betGE (PROTEIN1) processes the inactive GE precursor to the proinflammatory cytokine.
LABEL>1
PROTEIN1 was also shown to cleave the precursor of PROTEIN2nterferon-gammGE (GE) at the authentic processing site with high efficiency, thereby activating GE and facilitating its export.
LABEL>1
PROTEIN1 was also shown to cleave the precursor of GEnterferon-gammGE (PROTEIN2) at the authentic processing site with high efficiency, thereby activating GE and facilitating its export.
LABEL>1
PROTEIN1 was also shown to cleave the precursor of GEnterferon-gammGE (GE) at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.
LABEL>1
Physical and functional interactions between the transcriptional inhibitors PROTEIN1 and PROTEIN2. Evidence toward a novel mechanism regulating muscle-specific gene expression.
LABEL>1
We have used an interaction cloning strategy to identify an inhibitory isoform of the GE transcription factor, PROTEIN1, that interacts with the transcriptional inhibitor PROTEIN2/GE.
LABEL>1
We have used an interaction cloning strategy to identify an inhibitory isoform of the GE transcription factor, PROTEIN1, that interacts with the transcriptional inhibitor GE/PROTEIN2.
LABEL>1
Further investigation indicated that the PROTEIN1/PROTEIN2 heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by GE/GE.
LABEL>1
Competitive binding of PROTEIN1 and GE to the PROTEIN2.
LABEL>1
Competitive binding of GE and PROTEIN1 to the PROTEIN2.
LABEL>1
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>1
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>1
PROTEIN1 interacts with protein phosphatases PROTEIN2 and GE and disrupts a G2/M cell-cycle checkpoint.
LABEL>1
PROTEIN1 interacts with protein phosphatases GE and PROTEIN2 and disrupts a G2/M cell-cycle checkpoint.
LABEL>1
We observed that the protein PROTEIN1 interacted with protein PROTEIN2erine-threonine phosphatase 2GE (GE), as well as GE (GE) in mammalian cells.
LABEL>1
We observed that the protein PROTEIN1 interacted with protein GEerine-threonine phosphatase 2GE (PROTEIN2), as well as GE (GE) in mammalian cells.
LABEL>1
We observed that the protein PROTEIN1 interacted with protein GEerine-threonine phosphatase 2GE (GE), as well as PROTEIN2 (GE) in mammalian cells.
LABEL>1
We observed that the protein PROTEIN1 interacted with protein GEerine-threonine phosphatase 2GE (GE), as well as GE (PROTEIN2) in mammalian cells.
LABEL>1
Thus PROTEIN1 is a cellular oncogene that targets PROTEIN2 and GE, both of which are targets for oncogenic viruses and chemical tumour promoters.
LABEL>1
Thus PROTEIN1 is a cellular oncogene that targets GE and PROTEIN2, both of which are targets for oncogenic viruses and chemical tumour promoters.
LABEL>1
Analysis of the human PROTEIN1/human PROTEIN2nterleukin-GE binding interface at the amino acid level: proposed mechanism of interaction.
LABEL>1
The interaction between PROTEIN1 (GE) and PROTEIN2L-GE (GE) is the initial and most specific step in the GE signaling pathway.
LABEL>1
The interaction between PROTEIN1 (GE) and GEL-GE (PROTEIN2) is the initial and most specific step in the GE signaling pathway.
LABEL>1
The interaction between GE (PROTEIN1) and PROTEIN2L-GE (GE) is the initial and most specific step in the GE signaling pathway.
LABEL>1
The interaction between GE (GE) and PROTEIN1L-GE (PROTEIN2) is the initial and most specific step in the GE signaling pathway.
LABEL>1
We studied the human PROTEIN1 (GE)/PROTEIN2 binding interface by a combination of molecular modelling and site-directed mutagenesis.
LABEL>1
We studied the human GE (PROTEIN1)/PROTEIN2 binding interface by a combination of molecular modelling and site-directed mutagenesis.
LABEL>1
Following this hypothesis, we altered in PROTEIN1 and PROTEIN2 residues predicted to reside in the contact region and to interact with each other.
LABEL>1
We studied the capacity of these mutants to form an PROTEIN1/PROTEIN2 complex and their ability to transduce the signal.
LABEL>1
Mutagenesis of the PROTEIN1rythropoietiGE (PROTEIN2) permits analysis of the contribution that individual amino acid residues make to GE (GE) binding.
LABEL>1
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1PGE, PROTEIN2) of the GE.
LABEL>1
Activated PROTEIN1 predominantly interacts with PROTEIN2.
LABEL>1
GE and PROTEIN1.PROTEIN2.
LABEL>1
Using epitope-tagging, interaction of PROTEIN1 basic-helix-loop-helix protein with the PROTEIN2 protein encoded by this novel cDNA was confirmed by immunoprecipitation experiments in COS7 cells.
LABEL>1
A cDNA encoding part of the PROTEIN1 protein sequence interacted with the PROTEIN2 basic-helix-loop-helix only when fused to a beta-galactosidase tag.
LABEL>1
Our finding that PROTEIN1 directly interacts with PROTEIN2 (GE), a common subunit of RNA polymerases, implies that GE directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).
LABEL>1
Our finding that PROTEIN1 directly interacts with GE (PROTEIN2), a common subunit of RNA polymerases, implies that GE directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).
LABEL>1
Delineation of the binding regions of these three proteins revealed that PROTEIN1, PROTEIN2, and GE each has two binding regions for the other two proteins.
LABEL>1
Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or PROTEIN2 in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both GE and GE.
LABEL>1
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or GE in a mutually exclusive manner, suggesting that PROTEIN1 transactivation requires the interactions of both PROTEIN2 and GE.
LABEL>1
Crystal structure of the PROTEIN1nterleukin-GE complexed with PROTEIN2.
LABEL>1
The binding of PROTEIN1 or GE to PROTEIN2 is an early step in GE signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
LABEL>1
The binding of GE or PROTEIN1 to PROTEIN2 is an early step in GE signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
LABEL>1
Here we report the three-dimensional structure of PROTEIN1 bound to the extracellular domain of PROTEIN2 (GE) at 2.5 A resolution.
LABEL>1
Here we report the three-dimensional structure of PROTEIN1 bound to the extracellular domain of GE (PROTEIN2) at 2.5 A resolution.
LABEL>1
PROTEIN1 binds to PROTEIN2 with a 1:1 stoichiometry.
LABEL>1
The crystal structure shows that PROTEIN1 consists of three immunoglobulin-like domains which wrap around PROTEIN2 in a manner distinct from the structures of previously described cytokine-receptor complexes.
LABEL>1
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists PROTEIN2 and GE and the GEGE-receptoGE GE (ref. 2).
LABEL>1
Three naturally occurring ligands for the GEL-GE (PROTEIN1) exist: the agonists GE and PROTEIN2 and the GEGE-receptoGE GE (ref. 2).
LABEL>1
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and GE and the PROTEIN1PROTEIN2-receptoGE PROTEIN3 (ref. 2).
LABEL>1
Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of PROTEIN1L1GE complexed with PROTEIN2.
LABEL>1
The catalytic domain of activated GE (PROTEIN1) is absolutely required for interaction with its specific inhibitor, PROTEIN2 (GE).
LABEL>1
The catalytic domain of activated GE (PROTEIN1) is absolutely required for interaction with its specific inhibitor, GE (PROTEIN2).
LABEL>1
Only the activated and not the latent forms of wild-type and C-terminal mutant des-(248-450)-PROTEIN1 proteins are able to form complexes with PROTEIN2.
LABEL>1
This demonstrates that the C-terminal hemopexin domain of GE, in contrast to the corresponding regions of PROTEIN1 and GE, does not interact with PROTEIN2.
LABEL>1
This demonstrates that the C-terminal hemopexin domain of GE, in contrast to the corresponding regions of GE and PROTEIN1, does not interact with PROTEIN2.
LABEL>1
In summary, we have shown that the integrity of the catalytic domain of PROTEIN1 and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN2, which further underlines the importance of this region for proper regulation of enzymatic activity of GE.
LABEL>1
Thymocyte activation induces the association of PROTEIN1 and GE with PROTEIN2.
LABEL>1
Thymocyte activation induces the association of GE and PROTEIN1 with PROTEIN2.
LABEL>1
We investigated whether PROTEIN1, which binds to tyrosine-phosphorylated PROTEIN2, interacts with GE following T cell activation.
LABEL>1
GE activity and the regulatory GE subunit of PROTEIN1 associated with PROTEIN2 in pervanadate-stimulated, but not in unstimulated thymocytes.
LABEL>1
A PROTEIN1 (GE) associated with PROTEIN2 and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.
LABEL>1
A GE (PROTEIN1) associated with PROTEIN2 and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.
LABEL>1
We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PROTEIN1 and GE to PROTEIN2.
LABEL>1
We conclude that stimulation of thymocytes with pervanadate induces the recruitment of GE and PROTEIN1 to PROTEIN2.
LABEL>1
GE prevents PROTEIN1/PROTEIN2 containing GE complexes formation in terminally differentiated myocytes.
LABEL>1
An GE complex containing mainly PROTEIN1 and PROTEIN2/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>1
An GE complex containing mainly PROTEIN1 and GE/PROTEIN2 (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>1
An GE complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN1/PROTEIN2 containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>1
Thus, during myogenic differentiation, formation of PROTEIN1 and PROTEIN2/GE containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.
LABEL>1
Thus, during myogenic differentiation, formation of PROTEIN1 and GE/PROTEIN2 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.
LABEL>1
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of PROTEIN1/PROTEIN2 to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (PROTEIN1, GE/GE, GE, GE/GE, and TRAFs) associated with both of the PROTEIN2 and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (PROTEIN1, GE/GE, GE, GE/GE, and TRAFs) associated with both of the GE and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, PROTEIN1/GE, GE, GE/GE, and TRAFs) associated with both of the PROTEIN2 and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/PROTEIN1, GE, GE/GE, and TRAFs) associated with both of the PROTEIN2 and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/PROTEIN1, GE, GE/GE, and TRAFs) associated with both of the GE and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, GE, PROTEIN1/GE, and TRAFs) associated with both of the PROTEIN2 and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, GE, PROTEIN1/GE, and TRAFs) associated with both of the GE and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, GE, GE/PROTEIN1, and TRAFs) associated with both of the PROTEIN2 and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, GE, GE/PROTEIN1, and TRAFs) associated with both of the GE and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>1
Human PROTEIN1 was first characterized as a PROTEIN2AGE based on the properties of its carboxyl-terminal domain.
LABEL>1
We now show that full-length PROTEIN1 interacts with activated PROTEIN2 in mammalian cells and defines a minimum region of 434 aa required for efficient GE binding.
LABEL>1
PROTEIN1 interacts with the "effector domain" of PROTEIN2 and employs some GE determinants that are common to, and others that are distinct from, those required for the binding of GE, a known GE effector.
LABEL>1
GE interacts with the "effector domain" of GE and employs some GE determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN1, a known PROTEIN2 effector.
LABEL>1
The same domain of PROTEIN1 that binds PROTEIN2 also interacts with 14-3-3 proteins, extending the similarity between GE and other GE effectors.
LABEL>1
When expressed in mammalian cells, the PROTEIN1 binding domain of PROTEIN2 can act as a dominant negative signal transduction blocker.
LABEL>1
This PROTEIN1 sequence shows preferential binding to the PROTEIN2 domain in vitro.
LABEL>1
Moreover, the amino-terminal domain of PROTEIN1 directly associates with, and is tyrosine phosphorylated by, PROTEIN2.
LABEL>1
Cross-family interaction between the bHLHZip PROTEIN1 and bZip PROTEIN2 proteins results in down-regulation of GE activity.
LABEL>1
A bZip protein, PROTEIN1, was found to efficiently interact with PROTEIN2.
LABEL>1
PROTEIN1 specifically interacts with PROTEIN2 but not with other closely related family members, GE, GE, GE, or with GE.
LABEL>1
Both the bHLHZip and the N-terminal regions of PROTEIN1 are required for efficient interaction with PROTEIN2.
LABEL>1
In vivo association between PROTEIN1 and PROTEIN2 has been demonstrated by co-immunoprecipitation.
LABEL>1
These data show that PROTEIN1 and PROTEIN2 physically and functionally interact demonstrating that cross-talk occurs between factors of distantly related transcription families.
LABEL>1
Recombinant PROTEIN1 induces the tyrosine-phosphorylation of PROTEIN2, GE and GE in cell lines expressing all of these ErbB-family receptors.
LABEL>1
Recombinant PROTEIN1 induces the tyrosine-phosphorylation of GE, PROTEIN2 and GE in cell lines expressing all of these ErbB-family receptors.
LABEL>1
Recombinant PROTEIN1 induces the tyrosine-phosphorylation of GE, GE and PROTEIN2 in cell lines expressing all of these ErbB-family receptors.
LABEL>1
However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with PROTEIN2 and/or GE, suggesting that signalling by GE is mediated by GE and/or GE receptors.
LABEL>1
However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with GE and/or PROTEIN2, suggesting that signalling by GE is mediated by GE and/or GE receptors.
LABEL>1
Interaction between PROTEIN1 protein and PROTEIN2 in response to DNA damage.
LABEL>1
Because cells lacking the protein tyrosine kinase GE are also defective in radiation-induced G1 arrest, we investigated the possibility that PROTEIN1 might interact with PROTEIN2 in response to radiation damage.
LABEL>1
Here we show that PROTEIN1 binds PROTEIN2 constitutively in control cells but not in AT cells.
LABEL>1
Our results demonstrate that the SH3 domain of PROTEIN1 interacts with a DPAPNPPHFP motif (residues 1,373-1,382) of PROTEIN2.
LABEL>1
These findings indicate that PROTEIN1 is involved in the activation of PROTEIN2 by DNA damage and this interaction may in part mediate radiation-induced G1 arrest.
LABEL>1
We show that the physical interaction between PROTEIN1 and PROTEIN2, a coactivator for GE, is not sufficient for repression of GE-mediated transcription.
LABEL>1
We show that the physical interaction between GE and PROTEIN1, a coactivator for PROTEIN2, is not sufficient for repression of GE-mediated transcription.
LABEL>1
Proto-oncoprotein PROTEIN1 interacts with PROTEIN2 in activated thymocytes and peripheral T cells.
LABEL>1
The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the GE and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN2, GE, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>1
The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the GE and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, PROTEIN2, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>1
The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the GE and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, GE, and PROTEIN2, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>1
Here we show that PROTEIN1 and PROTEIN2 form inducible molecular complexes in GE-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.
LABEL>1
PROTEIN1/PROTEIN2 interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor GE, in which GE is hyperphosphorylated on tyrosine residues.
LABEL>1
The interaction between PROTEIN1 and PROTEIN2 is directly mediated via the SH2 domain of GE and is dependent on tyrosine phosphorylation of GE.
LABEL>1
In addition, we show that the conserved motif Y699 MTP present in PROTEIN1 is the binding site for the PROTEIN2 SH2 domain in vitro.
LABEL>1
Induction of cell migration by PROTEIN1 cleavage of PROTEIN2.
LABEL>1
Specific cleavage of PROTEIN1 (GE) by PROTEIN2 (GE) was shown to induce migration of breast epithelial cells.
LABEL>1
Specific cleavage of PROTEIN1 (GE) by GE (PROTEIN2) was shown to induce migration of breast epithelial cells.
LABEL>1
Specific cleavage of GE (PROTEIN1) by PROTEIN2 (GE) was shown to induce migration of breast epithelial cells.
LABEL>1
Specific cleavage of GE (PROTEIN1) by GE (PROTEIN2) was shown to induce migration of breast epithelial cells.
LABEL>1
PROTEIN1 cleaved the PROTEIN2n-GE subunit at residue 587, exposing a putative cryptic promigratory site on GE that triggers cell motility.
LABEL>1
Cleavage of PROTEIN1 by PROTEIN2 and the resulting activation of the GE cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.
LABEL>1
The PROTEIN1-PROTEIN2 complex: structural basis for GTPase activation and its loss in oncogenic GE mutants.
LABEL>1
The three-dimensional structure of the complex between human PROTEIN1 bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GE PROTEIN2 (GE) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
LABEL>1
The three-dimensional structure of the complex between human PROTEIN1 bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GE GE (PROTEIN2) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
LABEL>1
The switch II region of PROTEIN1 is stabilized by PROTEIN2, thus allowing glutamine-61 of GE, mutation of which activates the oncogenic potential, to participate in catalysis.
LABEL>1
Characterization of PROTEIN1 (GE, GE)-PROTEIN2aGE interaction.
LABEL>1
Characterization of GE (PROTEIN1, GE)-PROTEIN2aGE interaction.
LABEL>1
Characterization of GE (GE, PROTEIN1)-PROTEIN2aGE interaction.
LABEL>1
The death-inducing receptor PROTEIN1 is activated when cross-linked by the type II membrane protein PROTEIN2aGE (GE).
LABEL>1
The death-inducing receptor PROTEIN1 is activated when cross-linked by the type II membrane protein GEaGE (PROTEIN2).
LABEL>1
The death-inducing receptor GE is activated when cross-linked by the type II membrane protein PROTEIN1aGE (PROTEIN2).
LABEL>1
Based on the structure of the closely related PROTEIN1-PROTEIN2 complex, a molecular model of the GE homotrimer bound to three GE molecules was generated using knowledge-based protein modeling methods.
LABEL>1
Based on the structure of the closely related GE-GE complex, a molecular model of the PROTEIN1 homotrimer bound to three PROTEIN2 molecules was generated using knowledge-based protein modeling methods.
LABEL>1
Although the cytotoxic activity of mutant Y218D was unaltered, mutant Y218R was inactive, correlating with the prediction that Tyr-218 of PROTEIN1 interacts with a cluster of three basic amino acid side chains of PROTEIN2.
LABEL>1
We sought to characterize how PROTEIN1 binds and activates its receptor, PROTEIN2.
LABEL>1
PROTEIN1 negatively regulates PROTEIN2 activity by interactions with the GE cysteine-rich domain.
LABEL>1
PROTEIN1 negatively regulates GE activity by interactions with the PROTEIN2 cysteine-rich domain.
LABEL>1
We recently reported that PROTEIN1 interaction with the PROTEIN2af-GE (GE, residues 139-184) may be required for GE activation.
LABEL>1
We recently reported that PROTEIN1 interaction with the GEaf-GE (PROTEIN2, residues 139-184) may be required for GE activation.
LABEL>1
In the present study, we demonstrate that PROTEIN1 binds directly to the isolated PROTEIN2.
LABEL>1
Moreover, mutation of PROTEIN1 residues 143-145 impairs binding of 14-3-3, but not PROTEIN2, to the GE.
LABEL>1
Moreover, mutation of PROTEIN1 residues 143-145 impairs binding of 14-3-3, but not GE, to the PROTEIN2.
LABEL>1
Interactions between PROTEIN1 and the PROTEIN2RKGE. Identification of two ligand binding domains in soluble GE by affinity separation and chemical cross-linking.
LABEL>1
The extracellular domain of the human PROTEIN1RKGE expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN2 (GE).
LABEL>1
The extracellular domain of the human PROTEIN1RKGE expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for GE (PROTEIN2).
LABEL>1
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1RKGE in binding PROTEIN2.
LABEL>1
A region of the beta subunit of the PROTEIN1nterferon alphGE different from box 1 interacts with PROTEIN2 and is sufficient to activate the GE-Stat pathway and induce an antiviral state.
LABEL>1
The protein product of PROTEIN1 proto-oncogene is known to interact with several proteins, including PROTEIN2, GE and GE, and is thought to regulate signalling by many cell surface receptors.
LABEL>1
The protein product of PROTEIN1 proto-oncogene is known to interact with several proteins, including GE, PROTEIN2 and GE, and is thought to regulate signalling by many cell surface receptors.
LABEL>1
The protein product of PROTEIN1 proto-oncogene is known to interact with several proteins, including GE, GE and PROTEIN2, and is thought to regulate signalling by many cell surface receptors.
LABEL>1
The precise function of GE in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN1 is a negative regulator of the PROTEIN2pidermal growth factoGE.
LABEL>1
The screen identified interactions involving PROTEIN1 and two 14-3-3 isoforms, PROTEIN2, human unconventional myosin IC, and a recently identified SH3 domain containing protein, GE.
LABEL>1
The screen identified interactions involving PROTEIN1 and two 14-3-3 isoforms, GE, human unconventional myosin IC, and a recently identified SH3 domain containing protein, PROTEIN2.
LABEL>1
Interaction between cell cycle regulator, PROTEIN1, and PROTEIN2 mediates repression of HIV-1 gene transcription.
LABEL>1
Some of these extracellular stimuli arrest cells in the G1 phase of the mitotic division cycle and modulate the activity of the tumor suppressor protein PROTEIN1 and its partner PROTEIN2.
LABEL>1
Here, we demonstrate that PROTEIN1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the GE enhancer region and to interact with the PROTEIN2 subunit, GE.
LABEL>1
Here, we demonstrate that PROTEIN1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the GE enhancer region and to interact with the GE subunit, PROTEIN2.
LABEL>1
Affinity chromatography and co-immunoprecipitation assays provide evidence for direct interaction of PROTEIN1 and PROTEIN2 in the absence of their DNA target sequences.
LABEL>1
The results of this study suggest that PROTEIN1 activity may be regulated by its interaction with the cell cycle regulatory protein, PROTEIN2.
LABEL>1
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the PROTEIN2 (GE) and GE, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>1
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the GE (PROTEIN2) and GE, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>1
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the GE (GE) and PROTEIN2, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>1
In addition, PROTEIN1 dissociates from PROTEIN2 upon binding of MHC class I leader sequence peptides.
LABEL>0
Taken together, our results suggest that GE may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the GE/PROTEIN1CKGE and the PROTEIN2nsuliGE.
LABEL>0
Taken together, our results suggest that GE may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the GE/PROTEIN1CKGE and the PROTEIN2nsuliGE.
LABEL>0
Taken together, our results suggest that GE may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the GE/PROTEIN1CKGE and the PROTEIN2nsuliGE.
LABEL>0
Taken together, our results suggest that GE may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the GE/GECKGE and the PROTEIN1nsuliGE.
LABEL>0
PROTEIN1 (PROTEIN2, GE, GE), a GE (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>0
PROTEIN1 (GE, PROTEIN2, GE), a GE (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>0
PROTEIN1 (GE, GE, PROTEIN2), a GE (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>0
GE (PROTEIN1, PROTEIN2, GE), a GE (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>0
GE (PROTEIN1, GE, PROTEIN2), a GE (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>0
GE (GE, PROTEIN1, PROTEIN2), a GE (GE) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>0
GE (GE, GE, GE), a PROTEIN1 (PROTEIN2) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.
LABEL>0
In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN1 and the PROTEIN2, GE (GE).
LABEL>0
In the yeast-based cloning system, the only strong interaction that was detected between GE and the PROTEIN1, PROTEIN2 (GE).
LABEL>0
In the yeast-based cloning system, the only strong interaction that was detected between GE and the PROTEIN1, GE (PROTEIN2).
LABEL>0
In the yeast-based cloning system, the only strong interaction that was detected between GE and the GE, PROTEIN1 (PROTEIN2).
LABEL>0
Surprisingly, the N-terminal third of PROTEIN1 alone bound GE more strongly than did intact PROTEIN2, suggesting that the protein's C-terminus may play a role in modulating the interaction with GE.
LABEL>0
Surprisingly, the N-terminal third of PROTEIN1 alone bound GE more strongly than did intact GE, suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN2.
LABEL>0
Surprisingly, the N-terminal third of GE alone bound PROTEIN1 more strongly than did intact GE, suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN2.
LABEL>0
Surprisingly, the N-terminal third of GE alone bound GE more strongly than did intact PROTEIN1, suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN2.
LABEL>0
The crystal structure of the PROTEIN1 core domain bound to the GE protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN2 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of GE.
LABEL>0
The crystal structure of the PROTEIN1 core domain bound to the GE protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of GE in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN2.
LABEL>0
The crystal structure of the GE core domain bound to the PROTEIN1 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN2 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of GE.
LABEL>0
The crystal structure of the GE core domain bound to the PROTEIN1 protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of GE in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN2.
LABEL>0
The crystal structure of the GE core domain bound to the GE protein, which contains an SH3 (Src homology 3) domain and four ankyrin repeats, revealed that (i) the SH3 domain binds the L3 loop of PROTEIN1 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes, and (ii) an ankyrin repeat, which forms an L-shaped structure consisting of a beta hairpin and two alpha helices, binds the L2 loop of PROTEIN2.
LABEL>0
The structure provides evidence that the PROTEIN1-GE complex forms in vivo and may have a critical role in the PROTEIN2 pathway of tumor suppression.
LABEL>0
The structure provides evidence that the GE-PROTEIN1 complex forms in vivo and may have a critical role in the PROTEIN2 pathway of tumor suppression.
LABEL>0
The GE oncoprotein is a cellular inhibitor of the PROTEIN1 tumor suppressor in that it can bind the transactivation domain of PROTEIN2 and downregulate its ability to activate transcription.
LABEL>0
In certain cancers, PROTEIN1 amplification is a common event and contributes to the inactivation of PROTEIN2.
LABEL>0
The crystal structure of the 109-residue amino-terminal domain of PROTEIN1 bound to a 15-residue transactivation domain peptide of GE revealed that PROTEIN2 has a deep hydrophobic cleft on which the GE peptide binds as an amphipathic alpha helix.
LABEL>0
The crystal structure of the 109-residue amino-terminal domain of PROTEIN1 bound to a 15-residue transactivation domain peptide of GE revealed that GE has a deep hydrophobic cleft on which the PROTEIN2 peptide binds as an amphipathic alpha helix.
LABEL>0
The crystal structure of the 109-residue amino-terminal domain of GE bound to a 15-residue transactivation domain peptide of PROTEIN1 revealed that PROTEIN2 has a deep hydrophobic cleft on which the GE peptide binds as an amphipathic alpha helix.
LABEL>0
The crystal structure of the 109-residue amino-terminal domain of GE bound to a 15-residue transactivation domain peptide of PROTEIN1 revealed that GE has a deep hydrophobic cleft on which the PROTEIN2 peptide binds as an amphipathic alpha helix.
LABEL>0
The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the PROTEIN2 alpha helix and, in particular, on a triad of GE amino acids-Phe19, Trp23, and Leu26-which insert deep into the GE cleft.
LABEL>0
The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the GE alpha helix and, in particular, on a triad of PROTEIN2 amino acids-Phe19, Trp23, and Leu26-which insert deep into the GE cleft.
LABEL>0
The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the GE alpha helix and, in particular, on a triad of GE amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN2 cleft.
LABEL>0
The interface relies on the steric complementarity between the GE cleft and the hydrophobic face of the PROTEIN1 alpha helix and, in particular, on a triad of PROTEIN2 amino acids-Phe19, Trp23, and Leu26-which insert deep into the GE cleft.
LABEL>0
The interface relies on the steric complementarity between the GE cleft and the hydrophobic face of the PROTEIN1 alpha helix and, in particular, on a triad of GE amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN2 cleft.
LABEL>0
These same PROTEIN1 residues are also involved in transactivation, supporting the hypothesis that PROTEIN2 inactivates GE by concealing its transactivation domain.
LABEL>0
These same PROTEIN1 residues are also involved in transactivation, supporting the hypothesis that GE inactivates PROTEIN2 by concealing its transactivation domain.
LABEL>0
The cytokine-activated tyrosine kinase PROTEIN1 activates GE in a PROTEIN2-dependent manner.
LABEL>0
The cytokine-activated tyrosine kinase GE activates PROTEIN1 in a PROTEIN2-dependent manner.
LABEL>0
PROTEIN1, a member of the Janus kinase superfamily was found to interact functionally with GE, a central component of the PROTEIN2/GE signal transduction pathway.
LABEL>0
PROTEIN1, a member of the Janus kinase superfamily was found to interact functionally with GE, a central component of the GE/PROTEIN2 signal transduction pathway.
LABEL>0
GE, a member of the Janus kinase superfamily was found to interact functionally with PROTEIN1, a central component of the PROTEIN2/GE signal transduction pathway.
LABEL>0
GE, a member of the Janus kinase superfamily was found to interact functionally with PROTEIN1, a central component of the GE/PROTEIN2 signal transduction pathway.
LABEL>0
GE, a member of the Janus kinase superfamily was found to interact functionally with GE, a central component of the PROTEIN1/PROTEIN2 signal transduction pathway.
LABEL>0
PROTEIN1 and several other cytokines that are known to activate PROTEIN2AKGE were also found to stimulate GEaf-GE activity toward GE in mammalian cells.
LABEL>0
PROTEIN1 and several other cytokines that are known to activate GEAKGE were also found to stimulate PROTEIN2af-GE activity toward GE in mammalian cells.
LABEL>0
PROTEIN1 and several other cytokines that are known to activate GEAKGE were also found to stimulate PROTEIN2af-GE activity toward GE in mammalian cells.
LABEL>0
PROTEIN1 and several other cytokines that are known to activate GEAKGE were also found to stimulate GEaf-GE activity toward PROTEIN2 in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate PROTEIN1AKGE were also found to stimulate GEaf-GE activity toward GE in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate PROTEIN1AKGE were also found to stimulate PROTEIN2af-GE activity toward GE in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate PROTEIN1AKGE were also found to stimulate PROTEIN2af-GE activity toward GE in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate PROTEIN1AKGE were also found to stimulate GEaf-GE activity toward PROTEIN2 in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate PROTEIN1AKGE were also found to stimulate PROTEIN2af-GE activity toward GE in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate PROTEIN1AKGE were also found to stimulate PROTEIN2af-GE activity toward GE in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate PROTEIN1AKGE were also found to stimulate GEaf-GE activity toward PROTEIN2 in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate GEAKGE were also found to stimulate PROTEIN1af-GE activity toward GE in mammalian cells.
LABEL>0
GE and several other cytokines that are known to activate GEAKGE were also found to stimulate PROTEIN1af-GE activity toward PROTEIN2 in mammalian cells.
LABEL>0
In the baculovirus coexpression system, PROTEIN1 was activated by GE in the presence of PROTEIN2.
LABEL>0
In the baculovirus coexpression system, GE was activated by PROTEIN1 in the presence of PROTEIN2.
LABEL>0
Under these conditions, a ternary complex of PROTEIN1, GE, and PROTEIN2 was observed.
LABEL>0
Under these conditions, a ternary complex of GE, PROTEIN1, and PROTEIN2 was observed.
LABEL>0
In contrast, in the absence of PROTEIN1, coexpression of PROTEIN2 and GE resulted in an overall decrease in the GE kinase activity.
LABEL>0
In contrast, in the absence of PROTEIN1, coexpression of GE and PROTEIN2 resulted in an overall decrease in the GE kinase activity.
LABEL>0
In contrast, in the absence of PROTEIN1, coexpression of GE and GE resulted in an overall decrease in the PROTEIN2 kinase activity.
LABEL>0
In contrast, in the absence of GE, coexpression of PROTEIN1 and PROTEIN2 resulted in an overall decrease in the GE kinase activity.
LABEL>0
In contrast, in the absence of GE, coexpression of PROTEIN1 and GE resulted in an overall decrease in the PROTEIN2 kinase activity.
LABEL>0
In contrast, in the absence of GE, coexpression of GE and PROTEIN1 resulted in an overall decrease in the PROTEIN2 kinase activity.
LABEL>0
In addition, PROTEIN1 phosphorylated GE at sites different from those phosphorylated by PROTEIN2.
LABEL>0
In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of PROTEIN1 coimmunoprecipitated with GE in lysates of cells in which PROTEIN2 was activated as judged by its state of tyrosine phosphorylation.
LABEL>0
In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of GE coimmunoprecipitated with PROTEIN1 in lysates of cells in which PROTEIN2 was activated as judged by its state of tyrosine phosphorylation.
LABEL>0
Taken together, these data suggest that PROTEIN1 and GE cooperate to activate PROTEIN2.
LABEL>0
Taken together, these data suggest that GE and PROTEIN1 cooperate to activate PROTEIN2.
LABEL>0
PROTEIN1-induced interaction of primary HIV-1 GE glycoproteins with the chemokine receptor PROTEIN2.
LABEL>0
GE-induced interaction of primary HIV-1 PROTEIN1 glycoproteins with the chemokine receptor PROTEIN2.
LABEL>0
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, PROTEIN1 and PROTEIN2, respectively, as well as the primary receptor GE (refs 1-6).
LABEL>0
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, PROTEIN1 and GE, respectively, as well as the primary receptor PROTEIN2 (refs 1-6).
LABEL>0
For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, GE and PROTEIN1, respectively, as well as the primary receptor PROTEIN2 (refs 1-6).
LABEL>0
Here we show that a complex of PROTEIN1, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with GE and inhibits the binding of the natural PROTEIN2 ligands, GE and GE (refs 7, 8).
LABEL>0
Here we show that a complex of PROTEIN1, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with GE and inhibits the binding of the natural GE ligands, PROTEIN2 and GE (refs 7, 8).
LABEL>0
Here we show that a complex of PROTEIN1, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with GE and inhibits the binding of the natural GE ligands, GE and PROTEIN2 (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with GE and inhibits the binding of the natural PROTEIN2 ligands, GE and GE (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with GE and inhibits the binding of the natural GE ligands, PROTEIN2 and GE (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with GE and inhibits the binding of the natural GE ligands, GE and PROTEIN2 (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with PROTEIN1 and inhibits the binding of the natural PROTEIN2 ligands, GE and GE (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with PROTEIN1 and inhibits the binding of the natural GE ligands, PROTEIN2 and GE (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with PROTEIN1 and inhibits the binding of the natural GE ligands, GE and PROTEIN2 (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with GE and inhibits the binding of the natural PROTEIN1 ligands, PROTEIN2 and GE (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with GE and inhibits the binding of the natural PROTEIN1 ligands, GE and PROTEIN2 (refs 7, 8).
LABEL>0
Here we show that a complex of GE, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble GE interacts specifically with GE and inhibits the binding of the natural GE ligands, PROTEIN1 and PROTEIN2 (refs 7, 8).
LABEL>0
The apparent affinity of the interaction between PROTEIN1 and GE was dramatically lower in the absence of soluble PROTEIN2.
LABEL>0
The apparent affinity of the interaction between GE and PROTEIN1 was dramatically lower in the absence of soluble PROTEIN2.
LABEL>0
Additionally, in the absence of PROTEIN1, an interaction between a two-domain PROTEIN2 fragment and GE was observed.
LABEL>0
Additionally, in the absence of PROTEIN1, an interaction between a two-domain GE fragment and PROTEIN2 was observed.
LABEL>0
A GE fragment retaining the PROTEIN1-binding site and overlapping epitopes was able to interact with PROTEIN2 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.
LABEL>0
Neutralizing antibodies directed against either PROTEIN1-induced or V3 epitopes on PROTEIN2 blocked the interaction of GE-GE complexes with GE.
LABEL>0
Neutralizing antibodies directed against either PROTEIN1-induced or V3 epitopes on GE blocked the interaction of PROTEIN2-GE complexes with GE.
LABEL>0
Neutralizing antibodies directed against either PROTEIN1-induced or V3 epitopes on GE blocked the interaction of GE-PROTEIN2 complexes with GE.
LABEL>0
Neutralizing antibodies directed against either PROTEIN1-induced or V3 epitopes on GE blocked the interaction of GE-GE complexes with PROTEIN2.
LABEL>0
Neutralizing antibodies directed against either GE-induced or V3 epitopes on PROTEIN1 blocked the interaction of PROTEIN2-GE complexes with GE.
LABEL>0
Neutralizing antibodies directed against either GE-induced or V3 epitopes on PROTEIN1 blocked the interaction of GE-PROTEIN2 complexes with GE.
LABEL>0
Neutralizing antibodies directed against either GE-induced or V3 epitopes on PROTEIN1 blocked the interaction of GE-GE complexes with PROTEIN2.
LABEL>0
These results suggest that HIV-1 attachment to PROTEIN1 creates a high-affinity binding site for PROTEIN2, leading to membrane fusion and virus entry.
LABEL>0
PROTEIN1 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the PROTEIN2nterleukin-1GE intracellular domain.
LABEL>0
GE recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the PROTEIN1nterleukin-1GE intracellular domain.
LABEL>0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the PROTEIN1nterleukin 1GEL-1GE, the STAT proteins activated by GE in different cell populations were first defined using electrophoretic mobility shift assays.
LABEL>0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the PROTEIN1nterleukin 1GEL-1GE, the STAT proteins activated by GE in different cell populations were first defined using electrophoretic mobility shift assays.
LABEL>0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the PROTEIN1nterleukin 1GEL-1GE, the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays.
LABEL>0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the PROTEIN1nterleukin 1GEL-1GE, the STAT proteins activated by GE in different cell populations were first defined using electrophoretic mobility shift assays.
LABEL>0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the GEnterleukin 1GEL-1GE, the STAT proteins activated by PROTEIN1 in different cell populations were first defined using electrophoretic mobility shift assays.
LABEL>0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the PROTEIN1nterleukin 1GEL-1GE, the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays.
LABEL>0
In all cells tested, GE activated PROTEIN1 and PROTEIN2 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
LABEL>0
PROTEIN1 also activated GE in Ba/F3 cells that stably expressed the murine PROTEIN2L-1GE.
LABEL>0
PROTEIN1 also activated GE in Ba/F3 cells that stably expressed the murine PROTEIN2L-1GE.
LABEL>0
GE also activated PROTEIN1 in Ba/F3 cells that stably expressed the murine PROTEIN2L-1GE.
LABEL>0
GE also activated PROTEIN1 in Ba/F3 cells that stably expressed the murine PROTEIN2L-1GE.
LABEL>0
GE also activated GE in Ba/F3 cells that stably expressed the murine PROTEIN1L-1GE.
LABEL>0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1L-1GE were found to be redundantly required for receptor function and for activation of GE but not for GE or Stat5.
LABEL>0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1L-1GE were found to be redundantly required for receptor function and for activation of PROTEIN2 but not for GE or Stat5.
LABEL>0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1L-1GE were found to be redundantly required for receptor function and for activation of GE but not for PROTEIN2 or Stat5.
LABEL>0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1L-1GE were found to be redundantly required for receptor function and for activation of GE but not for PROTEIN2 or Stat5.
LABEL>0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine GEL-1GE were found to be redundantly required for receptor function and for activation of PROTEIN1 but not for PROTEIN2 or Stat5.
LABEL>0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN1 but not PROTEIN2 and blocked GE-induced GE phosphorylation in a cell-free system.
LABEL>0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN1 but not GE and blocked PROTEIN2-induced GE phosphorylation in a cell-free system.
LABEL>0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN1 but not GE and blocked GE-induced PROTEIN2 phosphorylation in a cell-free system.
LABEL>0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated GE but not PROTEIN1 and blocked PROTEIN2-induced GE phosphorylation in a cell-free system.
LABEL>0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated GE but not PROTEIN1 and blocked GE-induced PROTEIN2 phosphorylation in a cell-free system.
LABEL>0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated GE but not GE and blocked PROTEIN1-induced PROTEIN2 phosphorylation in a cell-free system.
LABEL>0
In contrast, tyrosine-phosphorylated peptides containing Tyr374 or Tyr396 did not interact with PROTEIN1 or block PROTEIN2 activation.
LABEL>0
These data demonstrate that PROTEIN1 but not PROTEIN2 or GE is directly recruited to the ligand-activated GEL-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that PROTEIN1 but not GE or PROTEIN2 is directly recruited to the ligand-activated GEL-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that PROTEIN1 but not GE or GE is directly recruited to the ligand-activated PROTEIN2L-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that GE but not PROTEIN1 or PROTEIN2 is directly recruited to the ligand-activated GEL-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that GE but not PROTEIN1 or GE is directly recruited to the ligand-activated PROTEIN2L-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that GE but not PROTEIN1 or GE is directly recruited to the ligand-activated PROTEIN2L-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that GE but not GE or PROTEIN1 is directly recruited to the ligand-activated PROTEIN2L-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that GE but not GE or PROTEIN1 is directly recruited to the ligand-activated PROTEIN2L-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
These data demonstrate that GE but not GE or GE is directly recruited to the ligand-activated PROTEIN1L-1GE by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
LABEL>0
cDNA cloning and characterization of the human PROTEIN1PROTEIN2 receptoGE.
LABEL>0
cDNA cloning and characterization of the human PROTEIN1PROTEIN2 receptoGE.
LABEL>0
cDNA cloning and characterization of the human PROTEIN1PROTEIN2 receptoGE.
LABEL>0
We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 receptoGE (GE).
LABEL>0
We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 receptoGE (GE).
LABEL>0
We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 receptoGE (PROTEIN3).
LABEL>0
We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 receptoGE (GE).
LABEL>0
We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 receptoGE (PROTEIN3).
LABEL>0
We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 receptoGE (PROTEIN3).
LABEL>0
Only weak PROTEIN1 binding activity was found in cells transfected with only GE; however, the combination of both PROTEIN2 and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the GEL-1GE.
LABEL>0
Only weak PROTEIN1 binding activity was found in cells transfected with only GE; however, the combination of both GE and PROTEIN2 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the GEL-1GE.
LABEL>0
Only weak PROTEIN1 binding activity was found in cells transfected with only GE; however, the combination of both GE and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak PROTEIN1 binding activity was found in cells transfected with only GE; however, the combination of both GE and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only PROTEIN1; however, the combination of both PROTEIN2 and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the GEL-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only PROTEIN1; however, the combination of both GE and PROTEIN2 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the GEL-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only PROTEIN1; however, the combination of both GE and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only PROTEIN1; however, the combination of both GE and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only GE; however, the combination of both PROTEIN1 and PROTEIN2 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the GEL-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only GE; however, the combination of both PROTEIN1 and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only GE; however, the combination of both PROTEIN1 and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only GE; however, the combination of both GE and PROTEIN1 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only GE; however, the combination of both GE and PROTEIN1 resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN2L-1GE.
LABEL>0
Only weak GE binding activity was found in cells transfected with only GE; however, the combination of both GE and GE resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the PROTEIN1L-1GE.
LABEL>0
Whereas PROTEIN1 serves as an alternative accessory protein to the common PROTEIN2 (GE) for GE signaling, it could not replace the function of GE in allowing enhanced GE binding activity.
LABEL>0
Whereas PROTEIN1 serves as an alternative accessory protein to the common GE (PROTEIN2) for GE signaling, it could not replace the function of GE in allowing enhanced GE binding activity.
LABEL>0
Whereas PROTEIN1 serves as an alternative accessory protein to the common GE (GE) for GE signaling, it could not replace the function of PROTEIN2 in allowing enhanced GE binding activity.
LABEL>0
Whereas PROTEIN1 serves as an alternative accessory protein to the common GE (GE) for GE signaling, it could not replace the function of GE in allowing enhanced PROTEIN2 binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common PROTEIN1 (PROTEIN2) for GE signaling, it could not replace the function of GE in allowing enhanced GE binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common PROTEIN1 (GE) for PROTEIN2 signaling, it could not replace the function of GE in allowing enhanced GE binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common PROTEIN1 (GE) for GE signaling, it could not replace the function of PROTEIN2 in allowing enhanced GE binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common PROTEIN1 (GE) for GE signaling, it could not replace the function of GE in allowing enhanced PROTEIN2 binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common GE (PROTEIN1) for PROTEIN2 signaling, it could not replace the function of GE in allowing enhanced GE binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common GE (PROTEIN1) for GE signaling, it could not replace the function of PROTEIN2 in allowing enhanced GE binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common GE (PROTEIN1) for GE signaling, it could not replace the function of GE in allowing enhanced PROTEIN2 binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common GE (GE) for PROTEIN1 signaling, it could not replace the function of PROTEIN2 in allowing enhanced GE binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common GE (GE) for PROTEIN1 signaling, it could not replace the function of GE in allowing enhanced PROTEIN2 binding activity.
LABEL>0
Whereas GE serves as an alternative accessory protein to the common GE (GE) for GE signaling, it could not replace the function of PROTEIN1 in allowing enhanced PROTEIN2 binding activity.
LABEL>0
Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN1 and PROTEIN2 are similar, and like GE, GE is located on chromosome X.
LABEL>0
Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN1 and GE are similar, and like PROTEIN2, GE is located on chromosome X.
LABEL>0
Nevertheless, the overall size and length of the cytoplasmic domain of PROTEIN1 and GE are similar, and like GE, PROTEIN2 is located on chromosome X.
LABEL>0
Nevertheless, the overall size and length of the cytoplasmic domain of GE and PROTEIN1 are similar, and like PROTEIN2, GE is located on chromosome X.
LABEL>0
Nevertheless, the overall size and length of the cytoplasmic domain of GE and PROTEIN1 are similar, and like GE, PROTEIN2 is located on chromosome X.
LABEL>0
Nevertheless, the overall size and length of the cytoplasmic domain of GE and GE are similar, and like PROTEIN1, PROTEIN2 is located on chromosome X.
LABEL>0
Aggregated PROTEIN1 (PROTEIN2) is a key component of the amyloid depositions found in the brains of patients with Alzheimer's disease.
LABEL>0
The analysis of complexes of PROTEIN1 with CSF proteins in a KBr gradient revealed an association of PROTEIN2 only with free proteins and not with lipoprotein particles.
LABEL>0
PROTEIN1 (PROTEIN2), a second major CSF protein, formed SDS-stable complexes with GE and significantly decreased the rate of GE fibril formation.
LABEL>0
PROTEIN1 (GE), a second major CSF protein, formed SDS-stable complexes with GE and significantly decreased the rate of PROTEIN2 fibril formation.
LABEL>0
GE (PROTEIN1), a second major CSF protein, formed SDS-stable complexes with GE and significantly decreased the rate of PROTEIN2 fibril formation.
LABEL>0
GE (GE), a second major CSF protein, formed SDS-stable complexes with PROTEIN1 and significantly decreased the rate of PROTEIN2 fibril formation.
LABEL>0
In physiological buffers and CSF, PROTEIN1 exclusively decreased the level of PROTEIN2 pentamers.
LABEL>0
We propose that PROTEIN1 binding proteins play a key role in the modulation of PROTEIN2 aggregation and normally prevent amyloid formation in biological fluids and in the brain.
LABEL>0
SREBP transcriptional activity is mediated through an interaction with the PROTEIN1REGE.
LABEL>0
In an unbiased search for potential coactivators of SREBP, we isolated a protein of 265 kD from HeLa cells that directly bound PROTEIN1 and PROTEIN2.
LABEL>0
Peptide sequencing and Western blot analysis established that the 265-kD protein was PROTEIN1 (PROTEIN2),a recently identified transcriptional coactivator.
LABEL>0
The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN1 and PROTEIN2 (a GE-related protein).
LABEL>0
The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN1 and GE (a PROTEIN2-related protein).
LABEL>0
The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant GE and PROTEIN1 (a PROTEIN2-related protein).
LABEL>0
Associations of GE with PROTEIN1, PROTEIN2, GE, and GE proteins in a yeast two-hybrid system.
LABEL>0
Associations of GE with PROTEIN1, GE, PROTEIN2, and GE proteins in a yeast two-hybrid system.
LABEL>0
Associations of GE with PROTEIN1, GE, GE, and PROTEIN2 proteins in a yeast two-hybrid system.
LABEL>0
Associations of GE with GE, PROTEIN1, PROTEIN2, and GE proteins in a yeast two-hybrid system.
LABEL>0
Associations of GE with GE, PROTEIN1, GE, and PROTEIN2 proteins in a yeast two-hybrid system.
LABEL>0
Associations of GE with GE, GE, PROTEIN1, and PROTEIN2 proteins in a yeast two-hybrid system.
LABEL>0
Using the human PROTEIN1 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN2, designated GE, that interacts with GE, GE, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human PROTEIN1 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated PROTEIN2, that interacts with GE, GE, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human PROTEIN1 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with PROTEIN2, GE, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human PROTEIN1 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with GE, PROTEIN2, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human PROTEIN1 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with GE, GE, PROTEIN2, and a ubiquitin-like protein GE.
LABEL>0
Using the human PROTEIN1 protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with GE, GE, GE, and a ubiquitin-like protein PROTEIN2.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1, designated PROTEIN2, that interacts with GE, GE, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1, designated GE, that interacts with PROTEIN2, GE, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1, designated GE, that interacts with GE, PROTEIN2, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1, designated GE, that interacts with GE, GE, PROTEIN2, and a ubiquitin-like protein GE.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast PROTEIN1, designated GE, that interacts with GE, GE, GE, and a ubiquitin-like protein PROTEIN2.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with PROTEIN1, PROTEIN2, GE, and a ubiquitin-like protein GE.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with PROTEIN1, GE, PROTEIN2, and a ubiquitin-like protein GE.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with PROTEIN1, GE, GE, and a ubiquitin-like protein PROTEIN2.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with GE, PROTEIN1, PROTEIN2, and a ubiquitin-like protein GE.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with GE, PROTEIN1, GE, and a ubiquitin-like protein PROTEIN2.
LABEL>0
Using the human GE protein as the "bait" in a yeast two-hybrid system, we have identified a human homolog of yeast GE, designated GE, that interacts with GE, GE, PROTEIN1, and a ubiquitin-like protein PROTEIN2.
LABEL>0
These interactions are PROTEIN1-specific, since another DNA repair-related ubiquitin-conjugating enzyme, PROTEIN2 (GE), does not interact with these proteins.
LABEL>0
These interactions are PROTEIN1-specific, since another DNA repair-related ubiquitin-conjugating enzyme, GE (PROTEIN2), does not interact with these proteins.
LABEL>0
These interactions are GE-specific, since another DNA repair-related ubiquitin-conjugating enzyme, PROTEIN1 (PROTEIN2), does not interact with these proteins.
LABEL>0
The interaction of PROTEIN1 with GE is mediated by PROTEIN2's self-association region.
LABEL>0
The interaction of GE with PROTEIN1 is mediated by PROTEIN2's self-association region.
LABEL>0
These results suggest that the PROTEIN1-dependent processes, cell cycle control, PROTEIN2-mediated pathway(s), and ubiquitination interact through human GE.
LABEL>0
These results suggest that the PROTEIN1-dependent processes, cell cycle control, GE-mediated pathway(s), and ubiquitination interact through human PROTEIN2.
LABEL>0
These results suggest that the GE-dependent processes, cell cycle control, PROTEIN1-mediated pathway(s), and ubiquitination interact through human PROTEIN2.
LABEL>0
Discrete protein interactions with the PROTEIN1/GE complex in PROTEIN2- and GE-mediated myeloid cell proliferation.
LABEL>0
Discrete protein interactions with the PROTEIN1/GE complex in GE- and PROTEIN2-mediated myeloid cell proliferation.
LABEL>0
Discrete protein interactions with the GE/PROTEIN1 complex in PROTEIN2- and GE-mediated myeloid cell proliferation.
LABEL>0
Discrete protein interactions with the GE/PROTEIN1 complex in GE- and PROTEIN2-mediated myeloid cell proliferation.
LABEL>0
Discrete protein interactions with the GE/GE complex in PROTEIN1- and PROTEIN2-mediated myeloid cell proliferation.
LABEL>0
Hemopoietic cell proliferation is mediated by non-tyrosine and tyrosine kinases that signal via uncommon and common sets of downstream effector molecules including the PROTEIN1/PROTEIN2.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the PROTEIN2/GE complex with signaling proteins upon activation of non-tyrosine (GE) and tyrosine kinase (GE) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the GE/PROTEIN2 complex with signaling proteins upon activation of non-tyrosine (GE) and tyrosine kinase (GE) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the GE/GE complex with signaling proteins upon activation of non-tyrosine (PROTEIN2) and tyrosine kinase (GE) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the GE/GE complex with signaling proteins upon activation of non-tyrosine (GE) and tyrosine kinase (PROTEIN2) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of GE and the interaction of the PROTEIN1/GE complex with signaling proteins upon activation of non-tyrosine (PROTEIN2) and tyrosine kinase (GE) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of GE and the interaction of the PROTEIN1/GE complex with signaling proteins upon activation of non-tyrosine (GE) and tyrosine kinase (PROTEIN2) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of GE and the interaction of the GE/PROTEIN1 complex with signaling proteins upon activation of non-tyrosine (PROTEIN2) and tyrosine kinase (GE) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of GE and the interaction of the GE/PROTEIN1 complex with signaling proteins upon activation of non-tyrosine (GE) and tyrosine kinase (PROTEIN2) receptors leading to myeloid cell proliferation.
LABEL>0
In the present study we evaluated tyrosine phosphorylation of GE and the interaction of the GE/GE complex with signaling proteins upon activation of non-tyrosine (PROTEIN1) and tyrosine kinase (PROTEIN2) receptors leading to myeloid cell proliferation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and PROTEIN2 ligands, namely: GE and GE, induce GE tyrosine phosphorylation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and GE ligands, namely: PROTEIN2 and GE, induce GE tyrosine phosphorylation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and GE ligands, namely: GE and PROTEIN2, induce GE tyrosine phosphorylation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and GE ligands, namely: GE and GE, induce PROTEIN2 tyrosine phosphorylation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both GE and PROTEIN1 ligands, namely: PROTEIN2 and GE, induce GE tyrosine phosphorylation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both GE and PROTEIN1 ligands, namely: GE and PROTEIN2, induce GE tyrosine phosphorylation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both GE and PROTEIN1 ligands, namely: GE and GE, induce PROTEIN2 tyrosine phosphorylation.
LABEL>0
By using the growth factor dependent M-07e cell line, we found that both GE and GE ligands, namely: PROTEIN1 and PROTEIN2, induce GE tyrosine phosphorylation.
LABEL>0
In vitro experiments showed that the stable PROTEIN1/GE complex interacts, through the PROTEIN2 SH2 domain, with the GE-activated GE.
LABEL>0
In vitro experiments showed that the stable PROTEIN1/GE complex interacts, through the GE SH2 domain, with the PROTEIN2-activated GE.
LABEL>0
In vitro experiments showed that the stable PROTEIN1/GE complex interacts, through the GE SH2 domain, with the GE-activated PROTEIN2.
LABEL>0
In vitro experiments showed that the stable GE/PROTEIN1 complex interacts, through the PROTEIN2 SH2 domain, with the GE-activated GE.
LABEL>0
In vitro experiments showed that the stable GE/PROTEIN1 complex interacts, through the GE SH2 domain, with the PROTEIN2-activated GE.
LABEL>0
In vitro experiments showed that the stable GE/PROTEIN1 complex interacts, through the GE SH2 domain, with the GE-activated PROTEIN2.
LABEL>0
In vitro experiments showed that the stable GE/GE complex interacts, through the PROTEIN1 SH2 domain, with the PROTEIN2-activated GE.
LABEL>0
By contrast stimulation with PROTEIN1 leads to the formation of a PROTEIN2 complex containing GE.
LABEL>0
By contrast stimulation with PROTEIN1 leads to the formation of a GE complex containing PROTEIN2.
LABEL>0
In vitro and in vivo experiments support the hypothesis that PROTEIN1 mediates the association of PROTEIN2 with GE.
LABEL>0
In vitro and in vivo experiments support the hypothesis that PROTEIN1 mediates the association of GE with PROTEIN2.
LABEL>0
Moreover we found that, upon PROTEIN1 stimulation, the PROTEIN2/GE complex recruits GE, probably via GE.
LABEL>0
Moreover we found that, upon PROTEIN1 stimulation, the GE/PROTEIN2 complex recruits GE, probably via GE.
LABEL>0
Moreover we found that, upon PROTEIN1 stimulation, the GE/GE complex recruits PROTEIN2, probably via GE.
LABEL>0
Moreover we found that, upon PROTEIN1 stimulation, the GE/GE complex recruits GE, probably via PROTEIN2.
LABEL>0
Moreover we found that, upon GE stimulation, the PROTEIN1/GE complex recruits PROTEIN2, probably via GE.
LABEL>0
Moreover we found that, upon GE stimulation, the PROTEIN1/GE complex recruits GE, probably via PROTEIN2.
LABEL>0
Moreover we found that, upon GE stimulation, the GE/PROTEIN1 complex recruits PROTEIN2, probably via GE.
LABEL>0
Moreover we found that, upon GE stimulation, the GE/PROTEIN1 complex recruits GE, probably via PROTEIN2.
LABEL>0
By contrast the PROTEIN1 exchanger factor (GE) was not detected in anti-PROTEIN2 immunoprecipitates suggesting that GE/GE and GE/GE are present in different complexes.
LABEL>0
By contrast the PROTEIN1 exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that PROTEIN2/GE and GE/GE are present in different complexes.
LABEL>0
By contrast the PROTEIN1 exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that GE/PROTEIN2 and GE/GE are present in different complexes.
LABEL>0
By contrast the PROTEIN1 exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that GE/GE and PROTEIN2/GE are present in different complexes.
LABEL>0
By contrast the PROTEIN1 exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that GE/GE and GE/PROTEIN2 are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (PROTEIN1) was not detected in anti-PROTEIN2 immunoprecipitates suggesting that GE/GE and GE/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (PROTEIN1) was not detected in anti-GE immunoprecipitates suggesting that PROTEIN2/GE and GE/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (PROTEIN1) was not detected in anti-GE immunoprecipitates suggesting that GE/PROTEIN2 and GE/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (PROTEIN1) was not detected in anti-GE immunoprecipitates suggesting that GE/GE and PROTEIN2/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (PROTEIN1) was not detected in anti-GE immunoprecipitates suggesting that GE/GE and GE/PROTEIN2 are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-PROTEIN1 immunoprecipitates suggesting that PROTEIN2/GE and GE/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-PROTEIN1 immunoprecipitates suggesting that GE/PROTEIN2 and GE/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-PROTEIN1 immunoprecipitates suggesting that GE/GE and PROTEIN2/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-PROTEIN1 immunoprecipitates suggesting that GE/GE and GE/PROTEIN2 are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that PROTEIN1/PROTEIN2 and GE/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that PROTEIN1/GE and PROTEIN2/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that PROTEIN1/GE and GE/PROTEIN2 are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that GE/PROTEIN1 and PROTEIN2/GE are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that GE/PROTEIN1 and GE/PROTEIN2 are present in different complexes.
LABEL>0
By contrast the GE exchanger factor (GE) was not detected in anti-GE immunoprecipitates suggesting that GE/GE and PROTEIN1/PROTEIN2 are present in different complexes.
LABEL>0
Taken together our results demonstrate that PROTEIN1 plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with PROTEIN2/GE complex when non-tyrosine or tyrosine kinase receptors are activated.
LABEL>0
Taken together our results demonstrate that PROTEIN1 plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with GE/PROTEIN2 complex when non-tyrosine or tyrosine kinase receptors are activated.
LABEL>0
We now find that HIV-1 begins reverse transcription much more efficiently in DCs than T cells, even though T cells have higher levels of PROTEIN1 and PROTEIN2 binding.
LABEL>0
PROTEIN1 interacts with GE and PROTEIN2 with GE receptors.
LABEL>0
PROTEIN1 interacts with GE and GE with PROTEIN2 receptors.
LABEL>0
GE interacts with PROTEIN1 and PROTEIN2 with GE receptors.
LABEL>0
GE interacts with PROTEIN1 and GE with PROTEIN2 receptors.
LABEL>0
DCs express more PROTEIN1 and PROTEIN2 mRNA than T cells.
LABEL>0
Activation of PROTEIN1nterferon-gammGE mediated by GEnterleukin-1betGE.
LABEL>0
Activation of PROTEIN1nterferon-gammGE mediated by PROTEIN2nterleukin-1betGE.
LABEL>0
Activation of PROTEIN1nterferon-gammGE mediated by PROTEIN2nterleukin-1betGE.
LABEL>0
Activation of PROTEIN1nterferon-gammGE mediated by PROTEIN2nterleukin-1betGE.
LABEL>0
Activation of GEnterferon-gammGE mediated by PROTEIN1nterleukin-1betGE.
LABEL>0
The PROTEIN1nterleukin-1betGEL-1betGE (GE) processes the inactive GE precursor to the proinflammatory cytokine.
LABEL>0
The PROTEIN1nterleukin-1betGEL-1betGE (GE) processes the inactive GE precursor to the proinflammatory cytokine.
LABEL>0
The PROTEIN1nterleukin-1betGEL-1betGE (GE) processes the inactive PROTEIN2 precursor to the proinflammatory cytokine.
LABEL>0
The PROTEIN1nterleukin-1betGEL-1betGE (GE) processes the inactive GE precursor to the proinflammatory cytokine.
LABEL>0
The GEnterleukin-1betGEL-1betGE (GE) processes the inactive PROTEIN1 precursor to the proinflammatory cytokine.
LABEL>0
The PROTEIN1nterleukin-1betGEL-1betGE (PROTEIN2) processes the inactive GE precursor to the proinflammatory cytokine.
LABEL>0
The PROTEIN1nterleukin-1betGEL-1betGE (GE) processes the inactive PROTEIN2 precursor to the proinflammatory cytokine.
LABEL>0
The GEnterleukin-1betGEL-1betGE (PROTEIN1) processes the inactive PROTEIN2 precursor to the proinflammatory cytokine.
LABEL>0
PROTEIN1 was also shown to cleave the precursor of PROTEIN2nterferon-gammGE (GE) at the authentic processing site with high efficiency, thereby activating GE and facilitating its export.
LABEL>0
GE was also shown to cleave the precursor of PROTEIN1nterferon-gammGE (GE) at the authentic processing site with high efficiency, thereby activating GE and facilitating its export.
LABEL>0
GE was also shown to cleave the precursor of PROTEIN1nterferon-gammGE (PROTEIN2) at the authentic processing site with high efficiency, thereby activating GE and facilitating its export.
LABEL>0
GE was also shown to cleave the precursor of PROTEIN1nterferon-gammGE (GE) at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.
LABEL>0
GE was also shown to cleave the precursor of PROTEIN1nterferon-gammGE (PROTEIN2) at the authentic processing site with high efficiency, thereby activating GE and facilitating its export.
LABEL>0
GE was also shown to cleave the precursor of PROTEIN1nterferon-gammGE (GE) at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.
LABEL>0
GE was also shown to cleave the precursor of GEnterferon-gammGE (PROTEIN1) at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.
LABEL>0
Lipopolysaccharide-activated PROTEIN1-deficient (ICE-/-) Kupffer cells synthesized the PROTEIN2 precursor but failed to process it into the active form.
LABEL>0
PROTEIN1 and PROTEIN2 were diminished in the sera of GE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.
LABEL>0
PROTEIN1 and GE were diminished in the sera of PROTEIN2-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.
LABEL>0
GE and PROTEIN1 were diminished in the sera of PROTEIN2-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.
LABEL>0
We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor, PROTEIN2, that interacts with the transcriptional inhibitor GE/GE.
LABEL>0
We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor, GE, that interacts with the transcriptional inhibitor PROTEIN2/GE.
LABEL>0
We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor, GE, that interacts with the transcriptional inhibitor GE/PROTEIN2.
LABEL>0
We have used an interaction cloning strategy to identify an inhibitory isoform of the GE transcription factor, GE, that interacts with the transcriptional inhibitor PROTEIN1/PROTEIN2.
LABEL>0
As expected, overexpression of either PROTEIN1/PROTEIN2 or GE effectively inhibited the activation of the muscle-specific GE promoter by the myogenic transcription factor GE.
LABEL>0
As expected, overexpression of either PROTEIN1/GE or PROTEIN2 effectively inhibited the activation of the muscle-specific GE promoter by the myogenic transcription factor GE.
LABEL>0
As expected, overexpression of either PROTEIN1/GE or GE effectively inhibited the activation of the muscle-specific PROTEIN2 promoter by the myogenic transcription factor GE.
LABEL>0
As expected, overexpression of either PROTEIN1/GE or GE effectively inhibited the activation of the muscle-specific GE promoter by the myogenic transcription factor PROTEIN2.
LABEL>0
As expected, overexpression of either GE/PROTEIN1 or PROTEIN2 effectively inhibited the activation of the muscle-specific GE promoter by the myogenic transcription factor GE.
LABEL>0
As expected, overexpression of either GE/PROTEIN1 or GE effectively inhibited the activation of the muscle-specific PROTEIN2 promoter by the myogenic transcription factor GE.
LABEL>0
As expected, overexpression of either GE/PROTEIN1 or GE effectively inhibited the activation of the muscle-specific GE promoter by the myogenic transcription factor PROTEIN2.
LABEL>0
As expected, overexpression of either GE/GE or PROTEIN1 effectively inhibited the activation of the muscle-specific PROTEIN2 promoter by the myogenic transcription factor GE.
LABEL>0
As expected, overexpression of either GE/GE or PROTEIN1 effectively inhibited the activation of the muscle-specific GE promoter by the myogenic transcription factor PROTEIN2.
LABEL>0
As expected, overexpression of either GE/GE or GE effectively inhibited the activation of the muscle-specific PROTEIN1 promoter by the myogenic transcription factor PROTEIN2.
LABEL>0
Moreover, while PROTEIN1 inhibited the PROTEIN2 promoter, it acted as a weak transactivator on an artificial promoter consisting of three tandem copies of the consensus myogenic factor DNA binding site.
LABEL>0
Further investigation indicated that the PROTEIN1/GE heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN2/GE.
LABEL>0
Further investigation indicated that the PROTEIN1/GE heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by GE/PROTEIN2.
LABEL>0
Further investigation indicated that the GE/PROTEIN1 heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN2/GE.
LABEL>0
Further investigation indicated that the GE/PROTEIN1 heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by GE/PROTEIN2.
LABEL>0
Further investigation indicated that the GE/GE heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN1/PROTEIN2.
LABEL>0
Additional analysis revealed the presence of transcripts for both the activating (PROTEIN1) and inhibitory (PROTEIN2) isoforms in differentiating C2C12 cultures, suggesting that both isoforms might participate in regulating the differentiation process.
LABEL>0
Competitive binding of PROTEIN1 and PROTEIN2 to the GE.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN2, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN2 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of PROTEIN2-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN2 subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/PROTEIN2 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/GE family of PROTEIN2-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN2 subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN1 family of PROTEIN2-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN1 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN1 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN1 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN1 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN2 subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN1 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/PROTEIN1 family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of PROTEIN1-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of PROTEIN1-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of PROTEIN1-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of PROTEIN1-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN2 subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of PROTEIN1-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of PROTEIN1-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1. PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1. GE binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN2 subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN2 subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and PROTEIN2 subunits of the GE, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and GE subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and GE subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN1 subunits of the PROTEIN2, and can be immunoprecipitated with NMDA receptors and GE from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and PROTEIN1 subunits of the GE, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of GE, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. GE, a member of the spectrin/GE family of GE-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule GE. GE binds by its central rod domain to the cytoplasmic tail of both GE and GE subunits of the PROTEIN1, and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.
LABEL>0
Intriguingly, PROTEIN1-PROTEIN2 binding is directly antagonized by Ca2+/GE.
LABEL>0
Intriguingly, PROTEIN1-GE binding is directly antagonized by Ca2+/PROTEIN2.
LABEL>0
Intriguingly, GE-PROTEIN1 binding is directly antagonized by Ca2+/PROTEIN2.
LABEL>0
GE interacts with protein phosphatases PROTEIN1 and PROTEIN2 and disrupts a G2/M cell-cycle checkpoint.
LABEL>0
We observed that the protein PROTEIN1 interacted with protein PROTEIN2erine-threonine phosphatase 2GE (GE), as well as GE (GE) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein PROTEIN1erine-threonine phosphatase 2GE (GE), as well as GE (GE) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein PROTEIN1erine-threonine phosphatase 2GE (PROTEIN2), as well as GE (GE) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein PROTEIN1erine-threonine phosphatase 2GE (GE), as well as PROTEIN2 (GE) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein PROTEIN1erine-threonine phosphatase 2GE (GE), as well as GE (PROTEIN2) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein PROTEIN1erine-threonine phosphatase 2GE (PROTEIN2), as well as GE (GE) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein PROTEIN1erine-threonine phosphatase 2GE (GE), as well as PROTEIN2 (GE) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein PROTEIN1erine-threonine phosphatase 2GE (GE), as well as GE (PROTEIN2) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein GEerine-threonine phosphatase 2GE (PROTEIN1), as well as PROTEIN2 (GE) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein GEerine-threonine phosphatase 2GE (PROTEIN1), as well as GE (PROTEIN2) in mammalian cells.
LABEL>0
We observed that the protein GE interacted with protein GEerine-threonine phosphatase 2GE (GE), as well as PROTEIN1 (PROTEIN2) in mammalian cells.
LABEL>0
Thus GE is a cellular oncogene that targets PROTEIN1 and PROTEIN2, both of which are targets for oncogenic viruses and chemical tumour promoters.
LABEL>0
Analysis of the human PROTEIN1/human PROTEIN2nterleukin-GE binding interface at the amino acid level: proposed mechanism of interaction.
LABEL>0
Analysis of the human GE/human PROTEIN1nterleukin-GE binding interface at the amino acid level: proposed mechanism of interaction.
LABEL>0
The interaction between PROTEIN1 (PROTEIN2) and GEL-GE (GE) is the initial and most specific step in the GE signaling pathway.
LABEL>0
The interaction between PROTEIN1 (GE) and PROTEIN2L-GE (GE) is the initial and most specific step in the GE signaling pathway.
LABEL>0
The interaction between PROTEIN1 (GE) and GEL-GE (GE) is the initial and most specific step in the PROTEIN2 signaling pathway.
LABEL>0
The interaction between GE (PROTEIN1) and PROTEIN2L-GE (GE) is the initial and most specific step in the GE signaling pathway.
LABEL>0
The interaction between GE (PROTEIN1) and GEL-GE (PROTEIN2) is the initial and most specific step in the GE signaling pathway.
LABEL>0
The interaction between GE (PROTEIN1) and GEL-GE (GE) is the initial and most specific step in the PROTEIN2 signaling pathway.
LABEL>0
The interaction between GE (GE) and PROTEIN1L-GE (GE) is the initial and most specific step in the GE signaling pathway.
LABEL>0
The interaction between GE (GE) and PROTEIN1L-GE (GE) is the initial and most specific step in the PROTEIN2 signaling pathway.
LABEL>0
The interaction between GE (GE) and PROTEIN1L-GE (PROTEIN2) is the initial and most specific step in the GE signaling pathway.
LABEL>0
The interaction between GE (GE) and PROTEIN1L-GE (GE) is the initial and most specific step in the PROTEIN2 signaling pathway.
LABEL>0
The interaction between GE (GE) and GEL-GE (PROTEIN1) is the initial and most specific step in the PROTEIN2 signaling pathway.
LABEL>0
We studied the human PROTEIN1 (PROTEIN2)/GE binding interface by a combination of molecular modelling and site-directed mutagenesis.
LABEL>0
Mutagenesis studies of the human PROTEIN1rythropoietiGE. Establishment of structure-function relationships.
LABEL>0
Mutagenesis of the PROTEIN1rythropoietiGE (GE) permits analysis of the contribution that individual amino acid residues make to GE (GE) binding.
LABEL>0
Mutagenesis of the PROTEIN1rythropoietiGE (GE) permits analysis of the contribution that individual amino acid residues make to PROTEIN2 (GE) binding.
LABEL>0
Mutagenesis of the PROTEIN1rythropoietiGE (GE) permits analysis of the contribution that individual amino acid residues make to GE (PROTEIN2) binding.
LABEL>0
Mutagenesis of the PROTEIN1rythropoietiGE (PROTEIN2) permits analysis of the contribution that individual amino acid residues make to GE (GE) binding.
LABEL>0
Mutagenesis of the PROTEIN1rythropoietiGE (GE) permits analysis of the contribution that individual amino acid residues make to PROTEIN2 (GE) binding.
LABEL>0
Mutagenesis of the PROTEIN1rythropoietiGE (GE) permits analysis of the contribution that individual amino acid residues make to GE (PROTEIN2) binding.
LABEL>0
Mutagenesis of the GErythropoietiGE (PROTEIN1) permits analysis of the contribution that individual amino acid residues make to PROTEIN2 (GE) binding.
LABEL>0
Mutagenesis of the GErythropoietiGE (PROTEIN1) permits analysis of the contribution that individual amino acid residues make to GE (PROTEIN2) binding.
LABEL>0
Mutagenesis of the GErythropoietiGE (GE) permits analysis of the contribution that individual amino acid residues make to PROTEIN1 (PROTEIN2) binding.
LABEL>0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1PGE, GE) of the GE.
LABEL>0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1PGE, GE) of the PROTEIN2.
LABEL>0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1PGE, PROTEIN2) of the GE.
LABEL>0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1PGE, GE) of the PROTEIN2.
LABEL>0
We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as GEPGE, PROTEIN1) of the PROTEIN2.
LABEL>0
Site-specific mutants were expressed in Escherichia coli as soluble PROTEIN1 and analyzed for PROTEIN2 binding in several different assay formats.
LABEL>0
In addition, selected mutant proteins were expressed as full-length PROTEIN1 on the surface of COS cells and analyzed for 125I-PROTEIN2 binding in receptor binding assays.
LABEL>0
Using these methods, we have identified residues that appear to be involved in PROTEIN1 binding as well as other residues, most of which are conserved in receptors of the cytokine receptor family, that appear to be necessary for the proper folding and/or stability of the PROTEIN2.
LABEL>0
Stimulation of PROTEIN1 (PROTEIN2) results in a variety of functional effects, including regulation of epithelial cell growth and differentiation.
LABEL>0
In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN2GFRGE and GEGFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN2GFRGE and GEGFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, GEGFRGE and PROTEIN2GFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, GEGFRGE and PROTEIN2GFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, GEGFRGE and GEGFRGE, that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1GFRGE and GEGFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1GFRGE and PROTEIN2GFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1GFRGE and PROTEIN2GFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1GFRGE and GEGFRGE, that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1GFRGE and PROTEIN2GFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1GFRGE and PROTEIN2GFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1GFRGE and GEGFRGE, that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, GEGFRGE and PROTEIN1GFRGE, that result from alternative splicing of exon III of the GE gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, GEGFRGE and PROTEIN1GFRGE, that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.
LABEL>0
In order to characterize the signaling pathway through which GE regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, GEGFRGE and PROTEIN1GFRGE, that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while GEGFRGE-expressing cells responded only to GE.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN2, -2, -4, and -6, while GEGFRGE-expressing cells responded only to GE.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while PROTEIN2GFRGE-expressing cells responded only to GE.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while PROTEIN2GFRGE-expressing cells responded only to GE.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while GEGFRGE-expressing cells responded only to PROTEIN2.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN2, -2, -4, and -6, while GEGFRGE-expressing cells responded only to GE.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while PROTEIN2GFRGE-expressing cells responded only to GE.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while PROTEIN2GFRGE-expressing cells responded only to GE.
LABEL>0
Expression of PROTEIN1GFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while GEGFRGE-expressing cells responded only to PROTEIN2.
LABEL>0
Expression of GEGFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1, -2, -4, and -6, while PROTEIN2GFRGE-expressing cells responded only to GE.
LABEL>0
Expression of GEGFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1, -2, -4, and -6, while PROTEIN2GFRGE-expressing cells responded only to GE.
LABEL>0
Expression of GEGFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1, -2, -4, and -6, while GEGFRGE-expressing cells responded only to PROTEIN2.
LABEL>0
Expression of GEGFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while PROTEIN1GFRGE-expressing cells responded only to GE.
LABEL>0
Expression of GEGFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while PROTEIN1GFRGE-expressing cells responded only to PROTEIN2.
LABEL>0
Expression of GEGFRGE in stably transfected L6 cells conferred growth responses to several members of the FGF family including GE, -2, -4, and -6, while PROTEIN1GFRGE-expressing cells responded only to PROTEIN2.
LABEL>0
Activation of PROTEIN1 upon ligand binding resulted in activation of PROTEIN2 pathway.
LABEL>0
PROTEIN1 utilizes two different pools of adapter protein PROTEIN2 to link to GE.
LABEL>0
PROTEIN1 utilizes two different pools of adapter protein GE to link to PROTEIN2.
LABEL>0
GE utilizes two different pools of adapter protein PROTEIN1 to link to PROTEIN2.
LABEL>0
PROTEIN1 in complex with a previously identified 90-kDa protein and designated protein PROTEIN2.
LABEL>0
Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of PROTEIN1, suggesting that the 66-kDa protein may play an important role in PROTEIN2-specific signaling.
LABEL>0
In addition to this unique pathway, PROTEIN1 also links to PROTEIN2.
LABEL>0
PROTEIN1 complex via the adapter protein PROTEIN2.
LABEL>0
Furthermore, activated PROTEIN1 was not able to induce dissociation of PROTEIN2.
LABEL>0
PROTEIN1 complex following PROTEIN2 phosphorylation.
LABEL>0
In summary, PROTEIN1 signaling pathway utilizes two PROTEIN2-containing complexes; GE.
LABEL>0
In summary, PROTEIN1 signaling pathway utilizes two GE-containing complexes; PROTEIN2.
LABEL>0
In summary, GE signaling pathway utilizes two PROTEIN1-containing complexes; PROTEIN2.
LABEL>0
PROTEIN1 and PROTEIN2.GE.
LABEL>0
PROTEIN1 and GE.PROTEIN2.
LABEL>0
PROTEIN1; these two complexes may alternatively link PROTEIN2 to GE.
LABEL>0
PROTEIN1; these two complexes may alternatively link GE to PROTEIN2.
LABEL>0
GE; these two complexes may alternatively link PROTEIN1 to PROTEIN2.
LABEL>0
Finally, activated PROTEIN1 was also found to result in phosphorylation of PROTEIN2 but reduced phosphorylation of GE.
LABEL>0
Finally, activated PROTEIN1 was also found to result in phosphorylation of GE but reduced phosphorylation of PROTEIN2.
LABEL>0
Finally, activated GE was also found to result in phosphorylation of PROTEIN1 but reduced phosphorylation of PROTEIN2.
LABEL>0
Interactions with human PROTEIN1 and mouse PROTEIN2 were confirmed using glutathione transferase-tagged cDNAs.
LABEL>0
PROTEIN1 is a transcriptional modulator that communicates with PROTEIN2 and the GE.
LABEL>0
PROTEIN1 is a transcriptional modulator that communicates with GE and the PROTEIN2.
LABEL>0
GE is a transcriptional modulator that communicates with PROTEIN1 and the PROTEIN2.
LABEL>0
PROTEIN1n (PROTEIN2) transactivates viral and cellular genes through a wide variety of cis-elements.
LABEL>0
Our finding that PROTEIN1 directly interacts with GE (GE), a common subunit of RNA polymerases, implies that PROTEIN2 directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).
LABEL>0
Our finding that GE directly interacts with PROTEIN1 (PROTEIN2), a common subunit of RNA polymerases, implies that GE directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).
LABEL>0
Our finding that GE directly interacts with PROTEIN1 (GE), a common subunit of RNA polymerases, implies that PROTEIN2 directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).
LABEL>0
Our finding that GE directly interacts with GE (PROTEIN1), a common subunit of RNA polymerases, implies that PROTEIN2 directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).
LABEL>0
In this context, we examined the possibility that PROTEIN1 and PROTEIN2 interact with other general transcription factors.
LABEL>0
PROTEIN1 and PROTEIN2 specifically bound to GE (GE) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
LABEL>0
PROTEIN1 and GE specifically bound to PROTEIN2 (GE) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
LABEL>0
PROTEIN1 and GE specifically bound to GE (PROTEIN2) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
LABEL>0
GE and PROTEIN1 specifically bound to PROTEIN2 (GE) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
LABEL>0
GE and PROTEIN1 specifically bound to GE (PROTEIN2) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
LABEL>0
GE and GE specifically bound to PROTEIN1 (PROTEIN2) in vitro, both of which were detected by either far-Western blotting or the glutathione S-transferase-resin pull-down assay.
LABEL>0
Delineation of the binding regions of these three proteins revealed that PROTEIN1, GE, and PROTEIN2 each has two binding regions for the other two proteins.
LABEL>0
Delineation of the binding regions of these three proteins revealed that GE, PROTEIN1, and PROTEIN2 each has two binding regions for the other two proteins.
LABEL>0
Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN2 or GE in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both GE and GE.
LABEL>0
Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or GE in a mutually exclusive manner, suggesting that PROTEIN2 transactivation requires the interactions of both GE and GE.
LABEL>0
Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or GE in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both PROTEIN2 and GE.
LABEL>0
Some PROTEIN1 substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or GE in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both GE and PROTEIN2.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or PROTEIN2 in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both GE and GE.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or GE in a mutually exclusive manner, suggesting that PROTEIN2 transactivation requires the interactions of both GE and GE.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or GE in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both PROTEIN2 and GE.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either PROTEIN1 or GE in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both GE and PROTEIN2.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or PROTEIN1 in a mutually exclusive manner, suggesting that PROTEIN2 transactivation requires the interactions of both GE and GE.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or PROTEIN1 in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both PROTEIN2 and GE.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or PROTEIN1 in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both GE and PROTEIN2.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or GE in a mutually exclusive manner, suggesting that PROTEIN1 transactivation requires the interactions of both GE and PROTEIN2.
LABEL>0
Some GE substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either GE or GE in a mutually exclusive manner, suggesting that GE transactivation requires the interactions of both PROTEIN1 and PROTEIN2.
LABEL>0
These results indicated that PROTEIN1 is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN2 through communication with GE and GE.
LABEL>0
These results indicated that PROTEIN1 is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and GE through communication with PROTEIN2 and GE.
LABEL>0
These results indicated that PROTEIN1 is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and GE through communication with GE and PROTEIN2.
LABEL>0
These results indicated that GE is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN1 through communication with PROTEIN2 and GE.
LABEL>0
These results indicated that GE is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and PROTEIN1 through communication with GE and PROTEIN2.
LABEL>0
These results indicated that GE is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between RNA polymerase and GE through communication with PROTEIN1 and PROTEIN2.
LABEL>0
Crystal structure of the PROTEIN1nterleukin-GE complexed with GE.
LABEL>0
Crystal structure of the GEnterleukin-GE complexed with PROTEIN1.
LABEL>0
PROTEIN1 (PROTEIN2) is an important mediator of inflammatory disease.
LABEL>0
The PROTEIN1 family currently consists of two agonists, PROTEIN2 and GE, and one antagonist, GE.
LABEL>0
The PROTEIN1 family currently consists of two agonists, GE and PROTEIN2, and one antagonist, GE.
LABEL>0
The PROTEIN1 family currently consists of two agonists, GE and GE, and one antagonist, PROTEIN2.
LABEL>0
The GE family currently consists of two agonists, PROTEIN1 and PROTEIN2, and one antagonist, GE.
LABEL>0
The GE family currently consists of two agonists, PROTEIN1 and GE, and one antagonist, PROTEIN2.
LABEL>0
The GE family currently consists of two agonists, GE and PROTEIN1, and one antagonist, PROTEIN2.
LABEL>0
Each of these molecules binds to the PROTEIN1L-GE (GE).
LABEL>0
Each of these molecules binds to the GEL-GE (PROTEIN1).
LABEL>0
Each of these molecules binds to the PROTEIN1L-GE (PROTEIN2).
LABEL>0
The binding of PROTEIN1 or PROTEIN2 to GE is an early step in GE signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
LABEL>0
The binding of PROTEIN1 or GE to GE is an early step in PROTEIN2 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
LABEL>0
The binding of GE or PROTEIN1 to GE is an early step in PROTEIN2 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
LABEL>0
The binding of GE or GE to PROTEIN1 is an early step in PROTEIN2 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.
LABEL>0
Here we report the three-dimensional structure of GE bound to the extracellular domain of PROTEIN1 (PROTEIN2) at 2.5 A resolution.
LABEL>0
A new cytokine-receptor binding mode revealed by the crystal structure of the PROTEIN1L-GE with an antagonist.
LABEL>0
Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN1 (PROTEIN2) and GE (ref. 1).
LABEL>0
Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN1 (GE) and PROTEIN2 (ref. 1).
LABEL>0
Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines GE (PROTEIN1) and PROTEIN2 (ref. 1).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (PROTEIN2) exist: the agonists GE and GE and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists PROTEIN2 and GE and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and PROTEIN2 and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the GEGE-receptoGE PROTEIN2 (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (PROTEIN2) exist: the agonists GE and GE and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and PROTEIN2 and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the PROTEIN1L-GE (GE) exist: the agonists GE and GE and the GEGE-receptoGE PROTEIN2 (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (PROTEIN1) exist: the agonists PROTEIN2 and GE and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (PROTEIN1) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (PROTEIN1) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (PROTEIN1) exist: the agonists GE and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (PROTEIN1) exist: the agonists GE and GE and the GEGE-receptoGE PROTEIN2 (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists PROTEIN1 and PROTEIN2 and the GEGE-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists PROTEIN1 and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists PROTEIN1 and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists PROTEIN1 and GE and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists PROTEIN1 and GE and the GEGE-receptoGE PROTEIN2 (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and PROTEIN1 and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and PROTEIN1 and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and PROTEIN1 and the PROTEIN2PROTEIN3-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and PROTEIN1 and the GEGE-receptoGE PROTEIN2 (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and GE and the PROTEIN1PROTEIN2-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and GE and the PROTEIN1PROTEIN2-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and GE and the PROTEIN1PROTEIN2-receptoGE PROTEIN3 (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and GE and the PROTEIN1PROTEIN2-receptoGE GE (ref. 2).
LABEL>0
Three naturally occurring ligands for the GEL-GE (GE) exist: the agonists GE and GE and the PROTEIN1PROTEIN2-receptoGE PROTEIN3 (ref. 2).
LABEL>0
Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of PROTEIN1L1GE complexed with GE.
LABEL>0
Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of GEL1GE complexed with PROTEIN1.
LABEL>0
A region that is important for biological function in PROTEIN1, the 'receptor trigger site' is not in direct contact with the receptor in the PROTEIN2 complex.
LABEL>0
The catalytic domain of activated PROTEIN1 (PROTEIN2) is absolutely required for interaction with its specific inhibitor, GE (GE).
LABEL>0
The catalytic domain of activated PROTEIN1 (GE) is absolutely required for interaction with its specific inhibitor, PROTEIN2 (GE).
LABEL>0
The catalytic domain of activated PROTEIN1 (GE) is absolutely required for interaction with its specific inhibitor, GE (PROTEIN2).
LABEL>0
The catalytic domain of activated GE (GE) is absolutely required for interaction with its specific inhibitor, PROTEIN1 (PROTEIN2).
LABEL>0
Here, we describe the production of PROTEIN1 (PROTEIN2) and wild-type and mutant human GE (GE) proteins in SF9 cells by the baculovirus expression system.
LABEL>0
Here, we describe the production of PROTEIN1 (GE) and wild-type and mutant human PROTEIN2 (GE) proteins in SF9 cells by the baculovirus expression system.
LABEL>0
Here, we describe the production of PROTEIN1 (GE) and wild-type and mutant human GE (PROTEIN2) proteins in SF9 cells by the baculovirus expression system.
LABEL>0
Here, we describe the production of GE (PROTEIN1) and wild-type and mutant human PROTEIN2 (GE) proteins in SF9 cells by the baculovirus expression system.
LABEL>0
Here, we describe the production of GE (PROTEIN1) and wild-type and mutant human GE (PROTEIN2) proteins in SF9 cells by the baculovirus expression system.
LABEL>0
Here, we describe the production of GE (GE) and wild-type and mutant human PROTEIN1 (PROTEIN2) proteins in SF9 cells by the baculovirus expression system.
LABEL>0
Wild-type PROTEIN1, as well as the PROTEIN2 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-GE], exhibit enzymatic activity upon cleavage of the prodomain by treatment with GE or 4-aminophenylmercuric acetate.
LABEL>0
Wild-type PROTEIN1, as well as the GE mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-PROTEIN2], exhibit enzymatic activity upon cleavage of the prodomain by treatment with GE or 4-aminophenylmercuric acetate.
LABEL>0
Wild-type PROTEIN1, as well as the GE mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-GE], exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate.
LABEL>0
Wild-type GE, as well as the PROTEIN1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-PROTEIN2], exhibit enzymatic activity upon cleavage of the prodomain by treatment with GE or 4-aminophenylmercuric acetate.
LABEL>0
Wild-type GE, as well as the PROTEIN1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-GE], exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate.
LABEL>0
Wild-type GE, as well as the GE mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-PROTEIN1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate.
LABEL>0
Deletion of the complete active-site [des-(161-228)-PROTEIN1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN2 proteins which are unable to digest GE or GE.
LABEL>0
Deletion of the complete active-site [des-(161-228)-PROTEIN1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of GE proteins which are unable to digest PROTEIN2 or GE.
LABEL>0
Deletion of the complete active-site [des-(161-228)-PROTEIN1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of GE proteins which are unable to digest GE or PROTEIN2.
LABEL>0
Deletion of the complete active-site [des-(161-228)-GE] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN1 proteins which are unable to digest PROTEIN2 or GE.
LABEL>0
Deletion of the complete active-site [des-(161-228)-GE] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN1 proteins which are unable to digest GE or PROTEIN2.
LABEL>0
Deletion of the complete active-site [des-(161-228)-GE] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of GE proteins which are unable to digest PROTEIN1 or PROTEIN2.
LABEL>0
In addition to co-immunoprecipitation analysis, we have established a rapid and sensitive ELISA assay using immobilized PROTEIN1 to determine the structural requirements of PROTEIN2 to form complexes with its inhibitor.
LABEL>0
Neither mutation of His199, nor deletion mutants des-(161-228)-PROTEIN1 and des-(161-228/248-450)-PROTEIN2, interact with GE.
LABEL>0
Neither mutation of His199, nor deletion mutants des-(161-228)-PROTEIN1 and des-(161-228/248-450)-GE, interact with PROTEIN2.
LABEL>0
Neither mutation of His199, nor deletion mutants des-(161-228)-GE and des-(161-228/248-450)-PROTEIN1, interact with PROTEIN2.
LABEL>0
This demonstrates that the C-terminal hemopexin domain of PROTEIN1, in contrast to the corresponding regions of PROTEIN2 and GE, does not interact with GE.
LABEL>0
This demonstrates that the C-terminal hemopexin domain of PROTEIN1, in contrast to the corresponding regions of GE and PROTEIN2, does not interact with GE.
LABEL>0
This demonstrates that the C-terminal hemopexin domain of PROTEIN1, in contrast to the corresponding regions of GE and GE, does not interact with PROTEIN2.
LABEL>0
This demonstrates that the C-terminal hemopexin domain of GE, in contrast to the corresponding regions of PROTEIN1 and PROTEIN2, does not interact with GE.
LABEL>0
In summary, we have shown that the integrity of the catalytic domain of PROTEIN1 and its ability to bind Zn2+ is absolutely required for complex formation with GE, which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN2.
LABEL>0
In summary, we have shown that the integrity of the catalytic domain of GE and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN1, which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN2.
LABEL>0
Thymocyte activation induces the association of PROTEIN1 and PROTEIN2 with GE.
LABEL>0
Antibody-mediated cross-linking studies or studies on PROTEIN1 knockout mice implicate PROTEIN2 as a co-stimulatory or negative regulatory molecule.
LABEL>0
Y429 and Y441 occur in an imperfect PROTEIN1 (PROTEIN2)-like sequence.
LABEL>0
We investigated whether PROTEIN1, which binds to tyrosine-phosphorylated GE, interacts with PROTEIN2 following T cell activation.
LABEL>0
We investigated whether GE, which binds to tyrosine-phosphorylated PROTEIN1, interacts with PROTEIN2 following T cell activation.
LABEL>0
PROTEIN1 activity and the regulatory PROTEIN2 subunit of GE associated with GE in pervanadate-stimulated, but not in unstimulated thymocytes.
LABEL>0
PROTEIN1 activity and the regulatory GE subunit of PROTEIN2 associated with GE in pervanadate-stimulated, but not in unstimulated thymocytes.
LABEL>0
PROTEIN1 activity and the regulatory GE subunit of GE associated with PROTEIN2 in pervanadate-stimulated, but not in unstimulated thymocytes.
LABEL>0
GE activity and the regulatory PROTEIN1 subunit of PROTEIN2 associated with GE in pervanadate-stimulated, but not in unstimulated thymocytes.
LABEL>0
GE activity and the regulatory PROTEIN1 subunit of GE associated with PROTEIN2 in pervanadate-stimulated, but not in unstimulated thymocytes.
LABEL>0
Cellular PROTEIN1 as well as the recombinant Src homology 2 (SH2) domains of PROTEIN2 bound a tyrosine-phosphorylated peptide encompassing Y463 with approximately threefold greater affinity than a doubly tyrosine-phosphorylated Y429-Y441 peptide.
LABEL>0
A PROTEIN1 (PROTEIN2) associated with GE and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.
LABEL>0
We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PROTEIN1 and PROTEIN2 to GE.
LABEL>0
As PROTEIN1 forms complexes with beta 1 integrins and the integrins are known to regulate keratinocyte behaviour, we investigated PROTEIN2 expression and function in human epidermal keratinocytes.
LABEL>0
There was extensive co-localisation of PROTEIN1 and beta 1 integrins on microvilli and at cell-cell borders of basal keratinocytes; however, in contrast to the integrins, PROTEIN2 was not found in focal adhesions.
LABEL>0
PROTEIN1 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of PROTEIN2 and GE, but not of cadherins.
LABEL>0
PROTEIN1 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of GE and PROTEIN2, but not of cadherins.
LABEL>0
GE was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of PROTEIN1 and PROTEIN2, but not of cadherins.
LABEL>0
PROTEIN1 was associated with alpha 3 beta 1 but not alpha 5 beta 1; small amounts of PROTEIN2 also co-immunoprecipitated with antibodies to alpha 2 beta 1 and alpha 6 beta 4.
LABEL>0
Antibodies to PROTEIN1 did not affect the proportion of keratinocytes that adhered to PROTEIN2, GE and GE, but did inhibit motility of keratinocytes on tissue culture plastic.
LABEL>0
Antibodies to PROTEIN1 did not affect the proportion of keratinocytes that adhered to GE, PROTEIN2 and GE, but did inhibit motility of keratinocytes on tissue culture plastic.
LABEL>0
Antibodies to PROTEIN1 did not affect the proportion of keratinocytes that adhered to GE, GE and PROTEIN2, but did inhibit motility of keratinocytes on tissue culture plastic.
LABEL>0
Antibodies to GE did not affect the proportion of keratinocytes that adhered to PROTEIN1, PROTEIN2 and GE, but did inhibit motility of keratinocytes on tissue culture plastic.
LABEL>0
Antibodies to GE did not affect the proportion of keratinocytes that adhered to PROTEIN1, GE and PROTEIN2, but did inhibit motility of keratinocytes on tissue culture plastic.
LABEL>0
Antibodies to GE did not affect the proportion of keratinocytes that adhered to GE, PROTEIN1 and PROTEIN2, but did inhibit motility of keratinocytes on tissue culture plastic.
LABEL>0
Like antibodies to the PROTEIN1 subunit, anti-PROTEIN2 inhibited suspension-induced terminal differentiation.
LABEL>0
PROTEIN1 prevents PROTEIN2/GE containing GE complexes formation in terminally differentiated myocytes.
LABEL>0
PROTEIN1 prevents GE/PROTEIN2 containing GE complexes formation in terminally differentiated myocytes.
LABEL>0
PROTEIN1 prevents GE/GE containing PROTEIN2 complexes formation in terminally differentiated myocytes.
LABEL>0
GE prevents PROTEIN1/GE containing PROTEIN2 complexes formation in terminally differentiated myocytes.
LABEL>0
GE prevents GE/PROTEIN1 containing PROTEIN2 complexes formation in terminally differentiated myocytes.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 (PROTEIN2) protein GE and the pocket proteins GE, GE and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 (GE) protein PROTEIN2 and the pocket proteins GE, GE and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 (GE) protein GE and the pocket proteins PROTEIN2, GE and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 (GE) protein GE and the pocket proteins GE, PROTEIN2 and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 (GE) protein GE and the pocket proteins GE, GE and PROTEIN2/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 (GE) protein GE and the pocket proteins GE, GE and GE/PROTEIN2.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (PROTEIN1) protein PROTEIN2 and the pocket proteins GE, GE and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (PROTEIN1) protein GE and the pocket proteins PROTEIN2, GE and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (PROTEIN1) protein GE and the pocket proteins GE, PROTEIN2 and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (PROTEIN1) protein GE and the pocket proteins GE, GE and PROTEIN2/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (PROTEIN1) protein GE and the pocket proteins GE, GE and GE/PROTEIN2.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein PROTEIN1 and the pocket proteins PROTEIN2, GE and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein PROTEIN1 and the pocket proteins GE, PROTEIN2 and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein PROTEIN1 and the pocket proteins GE, GE and PROTEIN2/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein PROTEIN1 and the pocket proteins GE, GE and GE/PROTEIN2.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein GE and the pocket proteins PROTEIN1, PROTEIN2 and GE/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein GE and the pocket proteins PROTEIN1, GE and PROTEIN2/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein GE and the pocket proteins PROTEIN1, GE and GE/PROTEIN2.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein GE and the pocket proteins GE, PROTEIN1 and PROTEIN2/GE.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein GE and the pocket proteins GE, PROTEIN1 and GE/PROTEIN2.
LABEL>0
Withdrawal from the cell cycle of differentiating myocytes is regulated by the GE (GE) protein GE and the pocket proteins GE, GE and PROTEIN1/PROTEIN2.
LABEL>0
An PROTEIN1 complex containing mainly PROTEIN2 and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An PROTEIN1 complex containing mainly GE and PROTEIN2/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An PROTEIN1 complex containing mainly GE and GE/PROTEIN2 (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An PROTEIN1 complex containing mainly GE and GE/GE (PROTEIN2-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An PROTEIN1 complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An PROTEIN1 complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/PROTEIN2 containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An PROTEIN1 complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing PROTEIN2 complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An PROTEIN1 complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
An GE complex containing mainly PROTEIN1 and GE/GE (PROTEIN2-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly PROTEIN1 and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly PROTEIN1 and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/PROTEIN2 containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly PROTEIN1 and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing PROTEIN2 complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly PROTEIN1 and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
An GE complex containing mainly GE and PROTEIN1/PROTEIN2 (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and PROTEIN1/GE (PROTEIN2-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and PROTEIN1/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and PROTEIN1/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/PROTEIN2 containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and PROTEIN1/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing PROTEIN2 complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and PROTEIN1/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/PROTEIN1 (PROTEIN2-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/PROTEIN1 (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/PROTEIN1 (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/PROTEIN2 containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/PROTEIN1 (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing PROTEIN2 complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/PROTEIN1 (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (PROTEIN1-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2/GE containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (PROTEIN1-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/PROTEIN2 containing GE complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (PROTEIN1-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing PROTEIN2 complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (PROTEIN1-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing GE complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN1/GE containing PROTEIN2 complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN1/GE containing GE complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/PROTEIN1 containing PROTEIN2 complex of proliferating myoblasts (GE-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/PROTEIN1 containing GE complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
An GE complex containing mainly GE and GE/GE (GE-G0/G1 complex) appears when DNA synthesis arrests, replacing the GE/GE containing PROTEIN1 complex of proliferating myoblasts (PROTEIN2-G1/S complex).
LABEL>0
In differentiating C2C12 cells, PROTEIN1 complexes switch and DNA synthesis in response to serum are prevented when PROTEIN2 DNA binding activity and the cdks inhibitor GE downstream effector GE are induced.
LABEL>0
In differentiating C2C12 cells, PROTEIN1 complexes switch and DNA synthesis in response to serum are prevented when GE DNA binding activity and the cdks inhibitor PROTEIN2 downstream effector GE are induced.
LABEL>0
In differentiating C2C12 cells, PROTEIN1 complexes switch and DNA synthesis in response to serum are prevented when GE DNA binding activity and the cdks inhibitor GE downstream effector PROTEIN2 are induced.
LABEL>0
In differentiating C2C12 cells, GE complexes switch and DNA synthesis in response to serum are prevented when PROTEIN1 DNA binding activity and the cdks inhibitor PROTEIN2 downstream effector GE are induced.
LABEL>0
In differentiating C2C12 cells, GE complexes switch and DNA synthesis in response to serum are prevented when PROTEIN1 DNA binding activity and the cdks inhibitor GE downstream effector PROTEIN2 are induced.
LABEL>0
In differentiating C2C12 cells, GE complexes switch and DNA synthesis in response to serum are prevented when GE DNA binding activity and the cdks inhibitor PROTEIN1 downstream effector PROTEIN2 are induced.
LABEL>0
Thus, during myogenic differentiation, formation of GE and PROTEIN1/PROTEIN2 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-PROTEIN2 (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-GE (PROTEIN2-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-GE (GE-PROTEIN2) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-GE (GE-GE) chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of PROTEIN2/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/PROTEIN2 to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-PROTEIN1 (PROTEIN2-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-PROTEIN1 (GE-PROTEIN2) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-PROTEIN1 (GE-GE) chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-PROTEIN1 (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of PROTEIN2/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-PROTEIN1 (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/PROTEIN2 to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-PROTEIN1 (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-PROTEIN1 (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (PROTEIN1-PROTEIN2) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (PROTEIN1-GE) chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (PROTEIN1-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of PROTEIN2/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (PROTEIN1-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/PROTEIN2 to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (PROTEIN1-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (PROTEIN1-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-PROTEIN1) chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-PROTEIN1) chimerae, we found that estrogen directed GE activation prevents the reassociation of PROTEIN2/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-PROTEIN1) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/PROTEIN2 to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-PROTEIN1) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-PROTEIN1) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of PROTEIN2/GE to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of GE/PROTEIN2 to the GE containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of GE/GE to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of GE/GE to the GE containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of PROTEIN1/GE to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of PROTEIN1/GE to the GE containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/PROTEIN1 to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of GE activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/PROTEIN1 to the GE containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing GE-GE (GE-GE) chimerae, we found that estrogen directed GE activation prevents the reassociation of GE/GE to the PROTEIN1 containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.
LABEL>0
Our data indicate that, in differentiating myocytes, one mechanism through which PROTEIN1 induces permanent cell cycle arrest involves PROTEIN2 upregulation and suppression of the proliferation-associated cdks-containing GE complexes formation.
LABEL>0
Our data indicate that, in differentiating myocytes, one mechanism through which PROTEIN1 induces permanent cell cycle arrest involves GE upregulation and suppression of the proliferation-associated cdks-containing PROTEIN2 complexes formation.
LABEL>0
Our data indicate that, in differentiating myocytes, one mechanism through which GE induces permanent cell cycle arrest involves PROTEIN1 upregulation and suppression of the proliferation-associated cdks-containing PROTEIN2 complexes formation.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (PROTEIN1, PROTEIN2/GE, GE, GE/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (PROTEIN1, GE/PROTEIN2, GE, GE/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (PROTEIN1, GE/GE, PROTEIN2, GE/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (PROTEIN1, GE/GE, GE, PROTEIN2/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (PROTEIN1, GE/GE, GE, GE/PROTEIN2, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, PROTEIN1/PROTEIN2, GE, GE/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, PROTEIN1/GE, PROTEIN2, GE/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, PROTEIN1/GE, GE, PROTEIN2/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, PROTEIN1/GE, GE, GE/PROTEIN2, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, PROTEIN1/GE, GE, GE/GE, and TRAFs) associated with both of the GE and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/PROTEIN1, PROTEIN2, GE/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/PROTEIN1, GE, PROTEIN2/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/PROTEIN1, GE, GE/PROTEIN2, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, PROTEIN1, PROTEIN2/GE, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, PROTEIN1, GE/PROTEIN2, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, PROTEIN1, GE/GE, and TRAFs) associated with both of the PROTEIN2 and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, PROTEIN1, GE/GE, and TRAFs) associated with both of the GE and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, GE, PROTEIN1/PROTEIN2, and TRAFs) associated with both of the GE and GE forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (GE, GE/GE, GE, GE/GE, and TRAFs) associated with both of the PROTEIN1 and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.
LABEL>0
Human PROTEIN1 was first characterized as a PROTEIN2AGE based on the properties of its carboxyl-terminal domain.
LABEL>0
Human GE was first characterized as a PROTEIN1AGE based on the properties of its carboxyl-terminal domain.
LABEL>0
We now show that full-length PROTEIN1 interacts with activated GE in mammalian cells and defines a minimum region of 434 aa required for efficient PROTEIN2 binding.
LABEL>0
We now show that full-length GE interacts with activated PROTEIN1 in mammalian cells and defines a minimum region of 434 aa required for efficient PROTEIN2 binding.
LABEL>0
PROTEIN1 interacts with the "effector domain" of GE and employs some PROTEIN2 determinants that are common to, and others that are distinct from, those required for the binding of GE, a known GE effector.
LABEL>0
PROTEIN1 interacts with the "effector domain" of GE and employs some GE determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN2, a known GE effector.
LABEL>0
PROTEIN1 interacts with the "effector domain" of GE and employs some GE determinants that are common to, and others that are distinct from, those required for the binding of GE, a known PROTEIN2 effector.
LABEL>0
GE interacts with the "effector domain" of PROTEIN1 and employs some PROTEIN2 determinants that are common to, and others that are distinct from, those required for the binding of GE, a known GE effector.
LABEL>0
GE interacts with the "effector domain" of PROTEIN1 and employs some GE determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN2, a known GE effector.
LABEL>0
GE interacts with the "effector domain" of PROTEIN1 and employs some GE determinants that are common to, and others that are distinct from, those required for the binding of GE, a known PROTEIN2 effector.
LABEL>0
GE interacts with the "effector domain" of GE and employs some PROTEIN1 determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN2, a known GE effector.
LABEL>0
GE interacts with the "effector domain" of GE and employs some PROTEIN1 determinants that are common to, and others that are distinct from, those required for the binding of GE, a known PROTEIN2 effector.
LABEL>0
The same domain of PROTEIN1 that binds GE also interacts with 14-3-3 proteins, extending the similarity between PROTEIN2 and other GE effectors.
LABEL>0
The same domain of PROTEIN1 that binds GE also interacts with 14-3-3 proteins, extending the similarity between GE and other PROTEIN2 effectors.
LABEL>0
The same domain of GE that binds PROTEIN1 also interacts with 14-3-3 proteins, extending the similarity between PROTEIN2 and other GE effectors.
LABEL>0
The same domain of GE that binds PROTEIN1 also interacts with 14-3-3 proteins, extending the similarity between GE and other PROTEIN2 effectors.
LABEL>0
The same domain of GE that binds GE also interacts with 14-3-3 proteins, extending the similarity between PROTEIN1 and other PROTEIN2 effectors.
LABEL>0
Cross-family interaction between the bHLHZip PROTEIN1 and bZip GE proteins results in down-regulation of PROTEIN2 activity.
LABEL>0
Cross-family interaction between the bHLHZip GE and bZip PROTEIN1 proteins results in down-regulation of PROTEIN2 activity.
LABEL>0
To further examine the function of the bHLHZip protein, PROTEIN1, we screened for cellular proteins which could directly interact with PROTEIN2 using the yeast two-hybrid system.
LABEL>0
PROTEIN1 specifically interacts with GE but not with other closely related family members, PROTEIN2, GE, GE, or with GE.
LABEL>0
PROTEIN1 specifically interacts with GE but not with other closely related family members, GE, PROTEIN2, GE, or with GE.
LABEL>0
PROTEIN1 specifically interacts with GE but not with other closely related family members, GE, GE, PROTEIN2, or with GE.
LABEL>0
PROTEIN1 specifically interacts with GE but not with other closely related family members, GE, GE, GE, or with PROTEIN2.
LABEL>0
GE specifically interacts with PROTEIN1 but not with other closely related family members, PROTEIN2, GE, GE, or with GE.
LABEL>0
GE specifically interacts with PROTEIN1 but not with other closely related family members, GE, PROTEIN2, GE, or with GE.
LABEL>0
GE specifically interacts with PROTEIN1 but not with other closely related family members, GE, GE, PROTEIN2, or with GE.
LABEL>0
GE specifically interacts with PROTEIN1 but not with other closely related family members, GE, GE, GE, or with PROTEIN2.
LABEL>0
GE specifically interacts with GE but not with other closely related family members, PROTEIN1, PROTEIN2, GE, or with GE.
LABEL>0
GE specifically interacts with GE but not with other closely related family members, PROTEIN1, GE, PROTEIN2, or with GE.
LABEL>0
GE specifically interacts with GE but not with other closely related family members, PROTEIN1, GE, GE, or with PROTEIN2.
LABEL>0
GE specifically interacts with GE but not with other closely related family members, GE, PROTEIN1, PROTEIN2, or with GE.
LABEL>0
GE specifically interacts with GE but not with other closely related family members, GE, PROTEIN1, GE, or with PROTEIN2.
LABEL>0
GE specifically interacts with GE but not with other closely related family members, GE, GE, PROTEIN1, or with PROTEIN2.
LABEL>0
Expression of exogenous PROTEIN1 led to a decrease in PROTEIN2-dependent transcription in F9 cells.
LABEL>0
Co-expression of exogenous PROTEIN1 restored the PROTEIN2 activity in a dose-dependent manner.
LABEL>0
Through their interaction with the ErbB family of receptors (PROTEIN1, PROTEIN2 and GE), neuregulins help to regulate cell growth and differentiation in many tissues.
LABEL>0
Through their interaction with the ErbB family of receptors (PROTEIN1, GE and PROTEIN2), neuregulins help to regulate cell growth and differentiation in many tissues.
LABEL>0
Through their interaction with the ErbB family of receptors (GE, PROTEIN1 and PROTEIN2), neuregulins help to regulate cell growth and differentiation in many tissues.
LABEL>0
The encoded product of the PROTEIN1 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the PROTEIN2(GE)-like domain gives rise to two isoforms (alpha and beta).
LABEL>0
The encoded product of the PROTEIN1 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the GE(PROTEIN2)-like domain gives rise to two isoforms (alpha and beta).
LABEL>0
The encoded product of the GE gene has a motif structure similar to that of neuregulins and an alternative splicing site in the PROTEIN1(PROTEIN2)-like domain gives rise to two isoforms (alpha and beta).
LABEL>0
Recombinant GE induces the tyrosine-phosphorylation of PROTEIN1, PROTEIN2 and GE in cell lines expressing all of these ErbB-family receptors.
LABEL>0
Recombinant GE induces the tyrosine-phosphorylation of PROTEIN1, GE and PROTEIN2 in cell lines expressing all of these ErbB-family receptors.
LABEL>0
Recombinant GE induces the tyrosine-phosphorylation of GE, PROTEIN1 and PROTEIN2 in cell lines expressing all of these ErbB-family receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with GE and/or GE, suggesting that signalling by PROTEIN2 is mediated by GE and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with GE and/or GE, suggesting that signalling by GE is mediated by PROTEIN2 and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with GE and/or GE, suggesting that signalling by GE is mediated by GE and/or PROTEIN2 receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with PROTEIN1 and/or PROTEIN2, suggesting that signalling by GE is mediated by GE and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with PROTEIN1 and/or GE, suggesting that signalling by PROTEIN2 is mediated by GE and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with PROTEIN1 and/or GE, suggesting that signalling by GE is mediated by PROTEIN2 and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with PROTEIN1 and/or GE, suggesting that signalling by GE is mediated by GE and/or PROTEIN2 receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with GE and/or PROTEIN1, suggesting that signalling by PROTEIN2 is mediated by GE and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with GE and/or PROTEIN1, suggesting that signalling by GE is mediated by PROTEIN2 and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with GE and/or PROTEIN1, suggesting that signalling by GE is mediated by GE and/or PROTEIN2 receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with GE and/or GE, suggesting that signalling by PROTEIN1 is mediated by PROTEIN2 and/or GE receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with GE and/or GE, suggesting that signalling by PROTEIN1 is mediated by GE and/or PROTEIN2 receptors.
LABEL>0
However, in cell lines with defined combinations of ErbBs, GE only activates those with GE and/or GE, suggesting that signalling by GE is mediated by PROTEIN1 and/or PROTEIN2 receptors.
LABEL>0
The gene mutated in the autosomal recessive disorder ataxia telangiectasia (AT), designated PROTEIN1 (for 'PROTEIN2'), is a member of a family of phosphatidylinositol-3-kinase-like enzymes that are involved in cell-cycle control, meiotic recombination, telomere length monitoring and DNA-damage response.
LABEL>0
Because cells lacking the protein tyrosine kinase PROTEIN1 are also defective in radiation-induced G1 arrest, we investigated the possibility that PROTEIN2 might interact with GE in response to radiation damage.
LABEL>0
Because cells lacking the protein tyrosine kinase PROTEIN1 are also defective in radiation-induced G1 arrest, we investigated the possibility that GE might interact with PROTEIN2 in response to radiation damage.
LABEL>0
In addition, previous work indicated that PROTEIN1 and PROTEIN2 might be involved in GE-mediated repression.
LABEL>0
In addition, previous work indicated that PROTEIN1 and GE might be involved in PROTEIN2-mediated repression.
LABEL>0
In addition, previous work indicated that GE and PROTEIN1 might be involved in PROTEIN2-mediated repression.
LABEL>0
We show that the physical interaction between PROTEIN1 and GE, a coactivator for PROTEIN2, is not sufficient for repression of GE-mediated transcription.
LABEL>0
We show that the physical interaction between PROTEIN1 and GE, a coactivator for GE, is not sufficient for repression of PROTEIN2-mediated transcription.
LABEL>0
We show that the physical interaction between GE and PROTEIN1, a coactivator for GE, is not sufficient for repression of PROTEIN2-mediated transcription.
LABEL>0
We show that the physical interaction between GE and GE, a coactivator for PROTEIN1, is not sufficient for repression of PROTEIN2-mediated transcription.
LABEL>0
Repression of PROTEIN1-directed transcription may be accomplished through direct physical interaction between PROTEIN2 and this activator.
LABEL>0
In contrast, physical interaction is not necessary for PROTEIN1 to repress PROTEIN2- and GE-mediated transcription.
LABEL>0
In contrast, physical interaction is not necessary for PROTEIN1 to repress GE- and PROTEIN2-mediated transcription.
LABEL>0
In contrast, physical interaction is not necessary for GE to repress PROTEIN1- and PROTEIN2-mediated transcription.
LABEL>0
The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the PROTEIN2 and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, GE, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the GE and associates with PROTEIN2 homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, GE, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with PROTEIN2 homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, GE, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN2, GE, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, PROTEIN2, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, GE, and PROTEIN2, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the GE and associates with PROTEIN1 homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN2, GE, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the GE and associates with PROTEIN1 homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, PROTEIN2, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the GE and associates with PROTEIN1 homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, GE, and PROTEIN2, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the GE and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN1, PROTEIN2, and GE, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the GE and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN1, GE, and PROTEIN2, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
The molecular adapter GE is rapidly tyrosine phosphorylated following stimulation through the GE and associates with GE homology domain-2 (SH2)/SH3 domain-containing adapters such as GE, PROTEIN1, and PROTEIN2, which interact with guanine nucleotide exchange factors specific for the Ras family.
LABEL>0
This suggests that PROTEIN1 may link PROTEIN2 activation to molecules that regulate GTP binding proteins.
LABEL>0
The SH2/SH3-containing protein PROTEIN1 also contains a guanine nucleotide exchange factor domain, and PROTEIN2 has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the GE.
LABEL>0
The SH2/SH3-containing protein PROTEIN1 also contains a guanine nucleotide exchange factor domain, and GE has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the PROTEIN2.
LABEL>0
The SH2/SH3-containing protein GE also contains a guanine nucleotide exchange factor domain, and PROTEIN1 has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the PROTEIN2.
LABEL>0
Here we show that PROTEIN1 and GE form inducible molecular complexes in PROTEIN2-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.
LABEL>0
Here we show that GE and PROTEIN1 form inducible molecular complexes in PROTEIN2-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.
LABEL>0
PROTEIN1/GE interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN2, in which GE is hyperphosphorylated on tyrosine residues.
LABEL>0
PROTEIN1/GE interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor GE, in which PROTEIN2 is hyperphosphorylated on tyrosine residues.
LABEL>0
GE/PROTEIN1 interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN2, in which GE is hyperphosphorylated on tyrosine residues.
LABEL>0
GE/PROTEIN1 interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor GE, in which PROTEIN2 is hyperphosphorylated on tyrosine residues.
LABEL>0
GE/GE interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN1, in which PROTEIN2 is hyperphosphorylated on tyrosine residues.
LABEL>0
The interaction between PROTEIN1 and GE is directly mediated via the SH2 domain of PROTEIN2 and is dependent on tyrosine phosphorylation of GE.
LABEL>0
The interaction between PROTEIN1 and GE is directly mediated via the SH2 domain of GE and is dependent on tyrosine phosphorylation of PROTEIN2.
LABEL>0
The interaction between GE and PROTEIN1 is directly mediated via the SH2 domain of PROTEIN2 and is dependent on tyrosine phosphorylation of GE.
LABEL>0
The interaction between GE and PROTEIN1 is directly mediated via the SH2 domain of GE and is dependent on tyrosine phosphorylation of PROTEIN2.
LABEL>0
The interaction between GE and GE is directly mediated via the SH2 domain of PROTEIN1 and is dependent on tyrosine phosphorylation of PROTEIN2.
LABEL>0
These data imply that PROTEIN1 is a molecular adapter that regulates the function of PROTEIN2 in thymocytes and peripheral T cells.
LABEL>0
Specific cleavage of PROTEIN1 (PROTEIN2) by GE (GE) was shown to induce migration of breast epithelial cells.
LABEL>0
Specific cleavage of GE (GE) by PROTEIN1 (PROTEIN2) was shown to induce migration of breast epithelial cells.
LABEL>0
PROTEIN1 cleaved the PROTEIN2n-GE subunit at residue 587, exposing a putative cryptic promigratory site on GE that triggers cell motility.
LABEL>0
PROTEIN1 cleaved the GEn-GE subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN2 that triggers cell motility.
LABEL>0
GE cleaved the PROTEIN1n-GE subunit at residue 587, exposing a putative cryptic promigratory site on GE that triggers cell motility.
LABEL>0
GE cleaved the PROTEIN1n-GE subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN2 that triggers cell motility.
LABEL>0
GE cleaved the PROTEIN1n-GE subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN2 that triggers cell motility.
LABEL>0
Cleavage of PROTEIN1 by GE and the resulting activation of the PROTEIN2 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.
LABEL>0
Cleavage of GE by PROTEIN1 and the resulting activation of the PROTEIN2 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.
LABEL>0
The PROTEIN1-GE complex: structural basis for GTPase activation and its loss in oncogenic PROTEIN2 mutants.
LABEL>0
The GE-PROTEIN1 complex: structural basis for GTPase activation and its loss in oncogenic PROTEIN2 mutants.
LABEL>0
The three-dimensional structure of the complex between human PROTEIN1 bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN2 GE (GE) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
LABEL>0
The three-dimensional structure of the complex between human GE bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN1 PROTEIN2 (GE) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
LABEL>0
The three-dimensional structure of the complex between human GE bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN1 GE (PROTEIN2) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
LABEL>0
The three-dimensional structure of the complex between human GE bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GE PROTEIN1 (PROTEIN2) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.
LABEL>0
An arginine side chain (arginine-789) of PROTEIN1 is supplied into the active site of PROTEIN2 to neutralize developing charges in the transition state.
LABEL>0
The switch II region of PROTEIN1 is stabilized by GE, thus allowing glutamine-61 of PROTEIN2, mutation of which activates the oncogenic potential, to participate in catalysis.
LABEL>0
The switch II region of GE is stabilized by PROTEIN1, thus allowing glutamine-61 of PROTEIN2, mutation of which activates the oncogenic potential, to participate in catalysis.
LABEL>0
Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of PROTEIN1 and glutamine-61 of PROTEIN2, and even its mutation to alanine would disturb the arrangements of residues in the transition state.
LABEL>0
Characterization of PROTEIN1 (PROTEIN2, GE)-GEaGE interaction.
LABEL>0
Characterization of PROTEIN1 (GE, PROTEIN2)-GEaGE interaction.
LABEL>0
Characterization of PROTEIN1 (GE, GE)-PROTEIN2aGE interaction.
LABEL>0
Characterization of GE (PROTEIN1, PROTEIN2)-GEaGE interaction.
LABEL>0
Characterization of GE (PROTEIN1, GE)-PROTEIN2aGE interaction.
LABEL>0
Characterization of GE (GE, PROTEIN1)-PROTEIN2aGE interaction.
LABEL>0
Characterization of GE (GE, GE)-PROTEIN1aGE interaction.
LABEL>0
The death-inducing receptor PROTEIN1 is activated when cross-linked by the type II membrane protein PROTEIN2aGE (GE).
LABEL>0
The death-inducing receptor GE is activated when cross-linked by the type II membrane protein PROTEIN1aGE (GE).
LABEL>0
The death-inducing receptor GE is activated when cross-linked by the type II membrane protein PROTEIN1aGE (PROTEIN2).
LABEL>0
When human soluble PROTEIN1 (sFasL, containing the extracellular portion) was expressed in human embryo kidney 293 cells, the three N-linked glycans of each PROTEIN2 monomer were found to be essential for efficient secretion.
LABEL>0
Based on the structure of the closely related PROTEIN1-GE complex, a molecular model of the PROTEIN2 homotrimer bound to three GE molecules was generated using knowledge-based protein modeling methods.
LABEL>0
Based on the structure of the closely related PROTEIN1-GE complex, a molecular model of the GE homotrimer bound to three PROTEIN2 molecules was generated using knowledge-based protein modeling methods.
LABEL>0
Based on the structure of the closely related GE-PROTEIN1 complex, a molecular model of the PROTEIN2 homotrimer bound to three GE molecules was generated using knowledge-based protein modeling methods.
LABEL>0
Based on the structure of the closely related GE-PROTEIN1 complex, a molecular model of the GE homotrimer bound to three PROTEIN2 molecules was generated using knowledge-based protein modeling methods.
LABEL>0
Mutants P206R, P206D, and P206F displayed reduced cytotoxicity toward PROTEIN1-positive cells with a concomitant decrease in the binding affinity for the recombinant PROTEIN2-immunoglobulin Fc fusion proteins.
LABEL>0
PROTEIN1 (PROTEIN2) is a hematopoietin important for megakaryocyte proliferation and production of blood platelets.
LABEL>0
The PROTEIN1-like domain of PROTEIN2 (TPO1-153) has been fused to the GE coat protein of M13 bacteriophage.
LABEL>0
The PROTEIN1-like domain of GE (TPO1-153) has been fused to the PROTEIN2 coat protein of M13 bacteriophage.
LABEL>0
The GE-like domain of PROTEIN1 (TPO1-153) has been fused to the PROTEIN2 coat protein of M13 bacteriophage.
LABEL>0
Phage enzyme-linked immunosorbent assay was used to determine affinities for binding to both the PROTEIN1 receptor and five anti-PROTEIN2-153 monoclonal antibodies.
LABEL>0
In contrast, the other three monoclonal antibodies, which were effective at blocking PROTEIN1 activity but did not block initial binding of PROTEIN2 to its receptor, had epitopes predominantly on helix or 3.
LABEL>0
These results suggest that PROTEIN1 has two distinct receptor-binding sites that function to dimerize PROTEIN2 receptors in a sequential fashion.
LABEL>0
GE negatively regulates PROTEIN1 activity by interactions with the PROTEIN2 cysteine-rich domain.
LABEL>0
Although PROTEIN1 is a critical effector of PROTEIN2 signaling and transformation, the mechanism by which GE promotes GE activation is complex and remains poorly understood.
LABEL>0
Although PROTEIN1 is a critical effector of GE signaling and transformation, the mechanism by which PROTEIN2 promotes GE activation is complex and remains poorly understood.
LABEL>0
Although PROTEIN1 is a critical effector of GE signaling and transformation, the mechanism by which GE promotes PROTEIN2 activation is complex and remains poorly understood.
LABEL>0
Although GE is a critical effector of PROTEIN1 signaling and transformation, the mechanism by which PROTEIN2 promotes GE activation is complex and remains poorly understood.
LABEL>0
Although GE is a critical effector of PROTEIN1 signaling and transformation, the mechanism by which GE promotes PROTEIN2 activation is complex and remains poorly understood.
LABEL>0
Although GE is a critical effector of GE signaling and transformation, the mechanism by which PROTEIN1 promotes PROTEIN2 activation is complex and remains poorly understood.
LABEL>0
We recently reported that PROTEIN1 interaction with the PROTEIN2af-GE (GE, residues 139-184) may be required for GE activation.
LABEL>0
We recently reported that PROTEIN1 interaction with the GEaf-GE (GE, residues 139-184) may be required for PROTEIN2 activation.
LABEL>0
We recently reported that GE interaction with the PROTEIN1af-GE (GE, residues 139-184) may be required for GE activation.
LABEL>0
We recently reported that GE interaction with the PROTEIN1af-GE (PROTEIN2, residues 139-184) may be required for GE activation.
LABEL>0
We recently reported that GE interaction with the PROTEIN1af-GE (GE, residues 139-184) may be required for PROTEIN2 activation.
LABEL>0
We recently reported that GE interaction with the PROTEIN1af-GE (PROTEIN2, residues 139-184) may be required for GE activation.
LABEL>0
We recently reported that GE interaction with the PROTEIN1af-GE (GE, residues 139-184) may be required for PROTEIN2 activation.
LABEL>0
We recently reported that GE interaction with the GEaf-GE (PROTEIN1, residues 139-184) may be required for PROTEIN2 activation.
LABEL>0
The PROTEIN1 is located in the NH2-terminal negative regulatory domain of PROTEIN2 and is highly homologous to cysteine-rich domains found in protein kinase C family members.
LABEL>0
Recent studies indicate that the structural integrity of the PROTEIN1 is also critical for PROTEIN2 interaction with 14-3-3 proteins.
LABEL>0
However, whether 14-3-3 proteins interact directly with the PROTEIN1 and how this interaction may mediate PROTEIN2 function has not been determined.
LABEL>0
Moreover, mutation of GE residues 143-145 impairs binding of 14-3-3, but not PROTEIN1, to the PROTEIN2.
LABEL>0
Thus, 14-3-3 interaction with the PROTEIN1 may serve in negative regulation of PROTEIN2 function by facilitating dissociation of 14-3-3 from the NH2 terminus of GE to promote subsequent events necessary for full activation of GE.
LABEL>0
Thus, 14-3-3 interaction with the PROTEIN1 may serve in negative regulation of GE function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN2 to promote subsequent events necessary for full activation of GE.
LABEL>0
Thus, 14-3-3 interaction with the PROTEIN1 may serve in negative regulation of GE function by facilitating dissociation of 14-3-3 from the NH2 terminus of GE to promote subsequent events necessary for full activation of PROTEIN2.
LABEL>0
Thus, 14-3-3 interaction with the GE may serve in negative regulation of PROTEIN1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN2 to promote subsequent events necessary for full activation of GE.
LABEL>0
Thus, 14-3-3 interaction with the GE may serve in negative regulation of PROTEIN1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of GE to promote subsequent events necessary for full activation of PROTEIN2.
LABEL>0
Thus, 14-3-3 interaction with the GE may serve in negative regulation of GE function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN1 to promote subsequent events necessary for full activation of PROTEIN2.
LABEL>0
Interactions between PROTEIN1 and the PROTEIN2RKGE. Identification of two ligand binding domains in soluble GE by affinity separation and chemical cross-linking.
LABEL>0
Interactions between PROTEIN1 and the GERKGE. Identification of two ligand binding domains in soluble PROTEIN2 by affinity separation and chemical cross-linking.
LABEL>0
Interactions between GE and the PROTEIN1RKGE. Identification of two ligand binding domains in soluble GE by affinity separation and chemical cross-linking.
LABEL>0
Interactions between GE and the PROTEIN1RKGE. Identification of two ligand binding domains in soluble PROTEIN2 by affinity separation and chemical cross-linking.
LABEL>0
Interactions between GE and the PROTEIN1RKGE. Identification of two ligand binding domains in soluble PROTEIN2 by affinity separation and chemical cross-linking.
LABEL>0
The extracellular domain of the human PROTEIN1RKGE expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for GE (GE).
LABEL>0
The extracellular domain of the human GERKGE expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN1 (GE).
LABEL>0
The extracellular domain of the human GERKGE expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for GE (PROTEIN1).
LABEL>0
The extracellular domain of the human GERKGE expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN1 (PROTEIN2).
LABEL>0
Two distinct ligand binding domains of PROTEIN1 were isolated from proteolytic digests of the receptor by affinity separation on immobilized PROTEIN2.
LABEL>0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1RKGE in binding GE.
LABEL>0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1RKGE in binding PROTEIN2.
LABEL>0
A region of the beta subunit of the PROTEIN1nterferon alphGE different from box 1 interacts with GE and is sufficient to activate the GE-Stat pathway and induce an antiviral state.
LABEL>0
A region of the beta subunit of the PROTEIN1nterferon alphGE different from box 1 interacts with PROTEIN2 and is sufficient to activate the GE-Stat pathway and induce an antiviral state.
LABEL>0
A region of the beta subunit of the PROTEIN1nterferon alphGE different from box 1 interacts with GE and is sufficient to activate the PROTEIN2-Stat pathway and induce an antiviral state.
LABEL>0
A region of the beta subunit of the PROTEIN1nterferon alphGE different from box 1 interacts with GE and is sufficient to activate the PROTEIN2-Stat pathway and induce an antiviral state.
LABEL>0
A region of the beta subunit of the GEnterferon alphGE different from box 1 interacts with PROTEIN1 and is sufficient to activate the PROTEIN2-Stat pathway and induce an antiviral state.
LABEL>0
Coexpression of the alpha and betaL subunits of the human PROTEIN1nterferon alphGEFNalphGE is required for the induction of an antiviral state by human GE.
LABEL>0
Coexpression of the alpha and betaL subunits of the human PROTEIN1nterferon alphGEFNalphGE is required for the induction of an antiviral state by human GE.
LABEL>0
Coexpression of the alpha and betaL subunits of the human PROTEIN1nterferon alphGEFNalphGE is required for the induction of an antiviral state by human PROTEIN2.
LABEL>0
Coexpression of the alpha and betaL subunits of the human PROTEIN1nterferon alphGEFNalphGE is required for the induction of an antiviral state by human GE.
LABEL>0
Coexpression of the alpha and betaL subunits of the human GEnterferon alphGEFNalphGE is required for the induction of an antiviral state by human PROTEIN1.
LABEL>0
Coexpression of the alpha and betaL subunits of the human PROTEIN1nterferon alphGEFNalphGE is required for the induction of an antiviral state by human PROTEIN2.
LABEL>0
Our results demonstrated that the first 82 amino acids (AAs) (AAs 265-346) of the cytoplasmic domain of the betaL chain are sufficient to activate the PROTEIN1-Stat pathway and trigger an antiviral state after PROTEIN2 binding to the receptor.
LABEL>0
This region of the betaL chain, required for PROTEIN1 binding and activation, contains the Box 1 motif that is important for the interaction of some cytokine receptors with PROTEIN2 kinases.
LABEL>0
The protein product of GE proto-oncogene is known to interact with several proteins, including PROTEIN1, PROTEIN2 and GE, and is thought to regulate signalling by many cell surface receptors.
LABEL>0
The protein product of GE proto-oncogene is known to interact with several proteins, including PROTEIN1, GE and PROTEIN2, and is thought to regulate signalling by many cell surface receptors.
LABEL>0
The protein product of GE proto-oncogene is known to interact with several proteins, including GE, PROTEIN1 and PROTEIN2, and is thought to regulate signalling by many cell surface receptors.
LABEL>0
The precise function of PROTEIN1 in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN2 is a negative regulator of the GEpidermal growth factoGE.
LABEL>0
The precise function of PROTEIN1 in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that GE is a negative regulator of the PROTEIN2pidermal growth factoGE.
LABEL>0
The precise function of PROTEIN1 in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that GE is a negative regulator of the PROTEIN2pidermal growth factoGE.
LABEL>0
The precise function of GE in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN1 is a negative regulator of the PROTEIN2pidermal growth factoGE.
LABEL>0
The precise function of GE in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that GE is a negative regulator of the PROTEIN1pidermal growth factoGE.
LABEL>0
The screen identified interactions involving GE and two 14-3-3 isoforms, PROTEIN1, human unconventional myosin IC, and a recently identified SH3 domain containing protein, PROTEIN2.
LABEL>0
The PROTEIN1/PROTEIN2 family of transcription factors is one of the main targets of cytokines and other agents that induce HIV-1 gene expression.
LABEL>0
Here, we demonstrate that PROTEIN1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN2 enhancer region and to interact with the GE subunit, GE.
LABEL>0
Here, we demonstrate that GE may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN1 enhancer region and to interact with the PROTEIN2 subunit, GE.
LABEL>0
Here, we demonstrate that GE may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the PROTEIN1 enhancer region and to interact with the GE subunit, PROTEIN2.
LABEL>0
Here, we demonstrate that GE may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the GE enhancer region and to interact with the PROTEIN1 subunit, PROTEIN2.
LABEL>0
Gel retardation and methylation interference assays show that PROTEIN1 is able to bind specifically to a site embedded within the two PROTEIN2 elements.
LABEL>0
Gel retardation/immunoblot analysis using purified PROTEIN1 and PROTEIN2 homodimers reveals the presence of complexes containing both proteins.
LABEL>0
In vitro transcription assay demonstrates that PROTEIN1 represses PROTEIN2 mediated transcription in a cell-free system.
LABEL>0
Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN1 and PROTEIN2 binding sites in GE mediated repression of HIV-1 promoter, in vivo.
LABEL>0
Functional studies in Jurkat T lymphocytic cells point to the importance of both the PROTEIN1 and GE binding sites in PROTEIN2 mediated repression of HIV-1 promoter, in vivo.
LABEL>0
Functional studies in Jurkat T lymphocytic cells point to the importance of both the GE and PROTEIN1 binding sites in PROTEIN2 mediated repression of HIV-1 promoter, in vivo.
LABEL>0
PROTEIN1- and PROTEIN2-dependent GE surface expression correlates with the binding of an MHC class I leader peptide.
LABEL>0
PROTEIN1- and GE-dependent PROTEIN2 surface expression correlates with the binding of an MHC class I leader peptide.
LABEL>0
GE- and PROTEIN1-dependent PROTEIN2 surface expression correlates with the binding of an MHC class I leader peptide.
LABEL>0
We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to PROTEIN2.
LABEL>0
Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN2 associates with the GE (GE) and GE, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that GE associates with the PROTEIN2 (GE) and GE, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that GE associates with the GE (PROTEIN2) and GE, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that GE associates with the GE (GE) and PROTEIN2, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that GE associates with the GE (GE) and GE, and that PROTEIN2 expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that GE associates with the GE (GE) and GE, and that GE expression is PROTEIN2-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the GE (GE) and GE, and that PROTEIN2 expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the GE (GE) and GE, and that GE expression is PROTEIN2-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the PROTEIN1 (PROTEIN2) and GE, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the PROTEIN1 (GE) and PROTEIN2, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the PROTEIN1 (GE) and GE, and that PROTEIN2 expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the PROTEIN1 (GE) and GE, and that GE expression is PROTEIN2-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the GE (PROTEIN1) and PROTEIN2, and that GE expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the GE (PROTEIN1) and GE, and that PROTEIN2 expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the GE (PROTEIN1) and GE, and that GE expression is PROTEIN2-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the GE (GE) and PROTEIN1, and that PROTEIN2 expression is GE-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the GE (GE) and PROTEIN1, and that GE expression is PROTEIN2-dependent and tapasin-dependent.
LABEL>0
Further studies on the interaction of GE with molecules in the endoplasmic reticulum revealed that GE associates with the GE (GE) and GE, and that PROTEIN1 expression is PROTEIN2-dependent and tapasin-dependent.
LABEL>0
The correlation between PROTEIN1 and MHC class I surface expression might be relevant to the function of PROTEIN2.
LABEL>0
Our results also show that, although these PROTEIN1 binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the PROTEIN2 complex and loaded onto GE molecules.
LABEL>0
Our results also show that, although these PROTEIN1 binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the GE complex and loaded onto PROTEIN2 molecules.
LABEL>0
Our results also show that, although these GE binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the PROTEIN1 complex and loaded onto PROTEIN2 molecules.
